delta.rank,pval,level,nseqs,term,name,p.adj
0,1.24E-07,5,2757,unknown,unknown,0
0,6.58E-06,3,26,GO:0048278;GO:0140056;GO:0022406,membrane docking,0
0,1.07E-05,2,69,GO:0001817,regulation of cytokine production,0
0,1.58E-05,2,45,GO:0043900,regulation of multi-organism process,0
0,2.26E-05,2,37,GO:0001818,negative regulation of cytokine production,0.01
0,3.48E-05,2,18,GO:0048211;GO:0035493;GO:0048280,vesicle fusion with Golgi apparatus,0.025
0,6.65E-05,2,26,GO:0032480;GO:0032479,regulation of type I interferon production,0.025
0,5.34E-05,2,44,GO:0009615,response to virus,0.028571429
0,7.29E-05,3,68,GO:0051640,organelle localization,0.033333333
0,0.000143796,4,8,GO:0040010;GO:0040009,regulation of growth rate,0.033333333
0,0.000212104,2,30,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,0.036111111
0,0.000131307,2,17,GO:0043901,negative regulation of multi-organism process,0.036363636
0,0.000205819,2,29,GO:0006906;GO:0090174;GO:0048284;GO:0061025,organelle fusion,0.038235294
0,0.000112263,2,8,GO:0048525,negative regulation of viral process,0.04
0,0.000194293,2,11,GO:0032727;GO:0032481;GO:0032647;GO:0032728,positive regulation of type I interferon production,0.040625
0,0.000182926,2,39,GO:0051091,positive regulation of DNA-binding transcription factor activity,0.043333333
0,0.000171396,2,20,GO:0032648,regulation of interferon-beta production,0.046428571
0,0.000170112,2,42,GO:0001819,positive regulation of cytokine production,0.05
0,0.000335473,4,19,GO:0050688,regulation of defense response to virus,0.068421053
0,0.000604754,2,27,GO:0045927,positive regulation of growth,0.121428571
0,0.000590287,2,91,GO:0015074,DNA integration,0.1225
0,0.000613953,5,15,GO:0050691;GO:0001922;GO:0001782;GO:0002260;GO:0001776;GO:0045779;GO:0046851;GO:0034104;GO:2000349;GO:2000348;GO:2000352;GO:1904036;GO:2000351;GO:1904035;GO:0043124;GO:0032703;GO:0090291;GO:0090289;GO:0034136;GO:0034122;GO:0034135;GO:0034121;GO:0034140;GO:0034139;GO:0070423;GO:0002753;GO:0035872;GO:0061043;GO:0072573;GO:0002507;GO:0031665;GO:0002832,negative regulation of toll-like receptor 2 signaling pathway,0.122727273
0,0.000820467,3,83,GO:0051707,response to other organism,0.165217391
0,0.001033911,2,26,GO:0002831,regulation of response to biotic stimulus,0.195833333
0,0.001174599,2,142,GO:0006955,immune response,0.214
0,0.001207388,5,16,GO:0000077;GO:0031570,DNA integrity checkpoint,0.217307692
0,0.001457862,2,186,GO:0051240,positive regulation of multicellular organismal process,0.231034483
0,0.001446436,2,22,GO:0008340,determination of adult lifespan,0.239285714
0,0.001606907,2,63,GO:0016050,vesicle organization,0.243333333
0,0.001679773,2,841,GO:0048518;GO:0048522,positive regulation of biological process,0.251612903
0,0.001912465,5,96,GO:0048193,Golgi vesicle transport,0.26875
0,0.001981855,2,98,GO:0051090,regulation of DNA-binding transcription factor activity,0.275757576
0,0.002098552,2,14,GO:0060346;GO:0060343;GO:0030501;GO:0045778;GO:0070169;GO:0045669,positive regulation of ossification,0.285294118
0,0.002625752,3,16,GO:0017015;GO:1903844;GO:0035583;GO:0030512;GO:0035581;GO:0071694;GO:1903845;GO:1900116;GO:1900115,regulation of cellular response to transforming growth factor beta stimulus,0.2875
0,0.002625752,2,16,GO:0030500;GO:0070167,regulation of biomineral tissue development,0.2875
0,0.002801867,8,11,GO:0007257,activation of JUN kinase activity,0.292682927
0,0.002899175,5,17,GO:0045667,regulation of osteoblast differentiation,0.294047619
0,0.003096166,2,8,GO:0006805,xenobiotic metabolic process,0.294318182
0,0.002347387,3,395,GO:0051239,regulation of multicellular organismal process,0.297222222
0,0.002585327,5,5,GO:0009060;GO:0045333,aerobic respiration,0.297368421
0,0.002481497,2,54,GO:0002697,regulation of immune effector process,0.298648649
0,0.002315624,2,183,GO:0043085;GO:0044093,positive regulation of molecular function,0.3
0,0.003067854,2,113,GO:0043207;GO:0009607,response to biotic stimulus,0.3
0,0.003337702,2,131,GO:0006278;GO:0071897,DNA biosynthetic process,0.307777778
0,0.003406466,3,6,GO:0045069;GO:1903900,regulation of viral genome replication,0.317391304
0,0.005081553,4,43,GO:0051050,positive regulation of transport,0.353571429
0,0.004915116,2,24,GO:0030278,regulation of ossification,0.354545455
0,0.004915116,2,24,GO:0090101;GO:0090288,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.354545455
0,0.004763581,2,14,GO:0010959,regulation of metal ion transport,0.362264151
0,0.004763581,2,14,GO:0034764;GO:0043270,positive regulation of ion transport,0.362264151
0,0.004553209,2,18,GO:0042035,regulation of cytokine biosynthetic process,0.366
0,0.004643043,3,50,GO:0009314,response to radiation,0.367647059
0,0.004453441,3,108,GO:0040008,regulation of growth,0.368367347
0,0.004290906,4,33,GO:0009064,glutamine family amino acid metabolic process,0.369791667
0,0.004228049,3,68,GO:0031347,regulation of defense response,0.371276596
0,0.005884321,2,184,GO:0006952,defense response,0.387931034
0,0.005828361,2,48,GO:0090287,regulation of cellular response to growth factor stimulus,0.39122807
0,0.00611969,2,20,GO:0030968,endoplasmic reticulum unfolded protein response,0.401694915
0,0.006262685,3,5,GO:0051965,positive regulation of synapse assembly,0.408333333
0,0.007238062,2,12,GO:0006536,glutamate metabolic process,0.464754098
0,0.007518158,2,33,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.474193548
0,0.007748281,2,17,GO:0010212,response to ionizing radiation,0.479365079
0,0.008570143,2,105,GO:0045087,innate immune response,0.51171875
0,0.008771815,3,16,GO:0051963,regulation of synapse assembly,0.517692308
0,0.008953059,3,42,GO:0045185;GO:0051235,maintenance of location,0.518939394
0,0.009472857,2,33,GO:0045926,negative regulation of growth,0.522463768
0,0.00937891,4,163,GO:0051241,negative regulation of multicellular organismal process,0.524264706
0,0.009344191,2,36,GO:0044272,sulfur compound biosynthetic process,0.530597015
0,0.009849914,5,153,GO:0034622,cellular protein-containing complex assembly,0.535714286
0,0.010027786,2,24,GO:0000187,activation of MAPK activity,0.535915493
0,0.010215027,5,95,GO:0045597,positive regulation of cell differentiation,0.5375
0,0.010402272,2,361,GO:0006259,DNA metabolic process,0.543835616
0,0.011050685,2,6,GO:0061640,cytoskeleton-dependent cytokinesis,0.571621622
0,0.011612017,4,30,GO:0000075,cell cycle checkpoint,0.574025974
0,0.01140042,4,141,GO:0051094,positive regulation of developmental process,0.58
0,0.011597432,2,5,GO:0045116,protein neddylation,0.580263158
0,0.011915178,4,65,GO:0032101,regulation of response to external stimulus,0.584615385
0,0.012717368,2,13,GO:0051047;GO:0050714;GO:0002793;GO:0051222;GO:1903532;GO:1904951,positive regulation of secretion,0.597530864
0,0.012633834,2,23,GO:0030308,negative regulation of cell growth,0.60125
0,0.012537755,2,145,GO:0016310;GO:0006468,phosphorylation,0.605063291
0,0.014112498,5,21,GO:0043269,regulation of ion transport,0.613483146
0,0.013918665,7,7,GO:0060997;GO:0097061;GO:0099173;GO:0106027,dendritic spine morphogenesis,0.613636364
0,0.013260459,2,6,GO:0050922;GO:0051964,negative regulation of chemotaxis,0.613855422
0,0.013870762,3,171,GO:0006974,cellular response to DNA damage stimulus,0.618390805
0,0.013184493,2,157,GO:0080134,regulation of response to stress,0.618902439
0,0.013781487,2,313,GO:0065009,regulation of molecular function,0.620348837
0,0.014531677,2,8,GO:0006904,vesicle docking involved in exocytosis,0.623333333
0,0.013561623,3,14,GO:0032663,regulation of interleukin-2 production,0.623809524
0,0.013749649,3,45,GO:0007346,regulation of mitotic cell cycle,0.624117647
0,0.015346409,2,6,GO:0042036,negative regulation of cytokine biosynthetic process,0.627894737
0,0.01518875,3,29,GO:0060070,canonical Wnt signaling pathway,0.629255319
0,0.015175428,2,158,GO:0009605,response to external stimulus,0.633870968
0,0.015059363,2,81,GO:1901605,alpha-amino acid metabolic process,0.635869565
0,0.015023624,2,7,GO:0007444,imaginal disc development,0.642307692
0,0.017603375,3,38,GO:0002224;GO:0002221;GO:0002758;GO:0002218,activation of innate immune response,0.7140625
0,0.017965945,1,256,GO:0002376,immune system process,0.721649485
0,0.018925534,6,9,GO:0030071;GO:0010965;GO:1902099;GO:0033047;GO:1905818;GO:0033045,regulation of mitotic sister chromatid segregation,0.733663366
0,0.018810692,5,12,GO:0006541,glutamine metabolic process,0.7365
0,0.019235286,3,41,GO:0034976,response to endoplasmic reticulum stress,0.736764706
0,0.01851348,2,6,GO:0007595,lactation,0.737755102
0,0.021234798,3,7,GO:0051293;GO:0051653,establishment of spindle localization,0.73963964
0,0.021072238,2,6,GO:0044703,multi-organism reproductive process,0.741363636
0,0.018751104,3,15,GO:0051607,defense response to virus,0.741919192
0,0.021838979,2,271,GO:2000026,regulation of multicellular organismal development,0.743421053
0,0.020920358,2,10,GO:0031572,G2 DNA damage checkpoint,0.745412844
0,0.021589104,3,38,GO:0043507;GO:0043506,regulation of JUN kinase activity,0.745535714
0,0.021824585,6,18,GO:0033044,regulation of chromosome organization,0.749557522
0,0.020566424,2,122,GO:0045944,positive regulation of transcription by RNA polymerase II,0.75
0,0.020864429,5,6,GO:0085020;GO:0090234;GO:0090230;GO:1902115;GO:0090169;GO:0090224,regulation of centromere complex assembly,0.750925926
0,0.020541801,5,6,GO:0006595;GO:0042401;GO:0009309,amine biosynthetic process,0.757075472
0,0.020493855,2,121,GO:0006281,DNA repair,0.762857143
0,0.020300005,6,6,GO:0032743;GO:0002726;GO:0002711;GO:0002720;GO:0002724;GO:0002718,positive regulation of interleukin-2 production,0.765384615
0,0.020237068,3,10,GO:2000377,regulation of reactive oxygen species metabolic process,0.770873786
0,0.023379835,2,18,GO:0048477;GO:0007292,female gamete generation,0.774152542
0,0.022982651,1,220,GO:0051704,multi-organism process,0.77826087
0,0.023372766,2,632,GO:0006950,response to stress,0.780769231
0,0.023367799,4,12,GO:0009069,serine family amino acid metabolic process,0.7875
0,0.024170824,3,8,GO:0071320;GO:0051591,response to cAMP,0.794583333
0,0.024068311,2,8,GO:0035282;GO:0001756,segmentation,0.797058824
0,0.024432821,2,167,GO:0002684;GO:0002682,regulation of immune system process,0.799586777
0,0.025576253,3,52,GO:0045089;GO:0031349;GO:0045088,regulation of innate immune response,0.820325203
0,0.025312015,2,13,GO:0051983,regulation of chromosome segregation,0.821311475
0,0.026638649,2,91,GO:0061024,membrane organization,0.82265625
0,0.026989479,6,7,GO:0019218,regulation of steroid metabolic process,0.822868217
0,0.026466999,3,8,GO:0007032,endosome organization,0.824015748
0,0.026338948,2,11,GO:0140029,exocytic process,0.825793651
0,0.025964495,3,42,GO:0050708;GO:0002791,regulation of peptide secretion,0.825806452
0,0.026248921,2,9,GO:0017156;GO:0016079;GO:0048489;GO:0097479;GO:0097480,synaptic vesicle transport,0.8304
0,0.027925693,2,17,GO:0018108;GO:0018212,peptidyl-tyrosine phosphorylation,0.841923077
0,0.028654428,2,357,GO:0033554;GO:0051716,cellular response to stimulus,0.850378788
0,0.02842935,3,7,GO:0046685,response to arsenic-containing substance,0.850381679
0,0.029591463,3,19,GO:0050869;GO:0050864;GO:0051250;GO:0002695;GO:0050866;GO:0070664;GO:0002634,negative regulation of cell activation,0.866296296
0,0.029919499,2,314,GO:0051128,regulation of cellular component organization,0.867279412
0,0.029495643,4,200,GO:0006886,intracellular protein transport,0.870522388
0,0.029309803,3,67,GO:0007219,Notch signaling pathway,0.871428571
0,0.030510514,2,28,GO:0007281,germ cell development,0.881751825
0,0.031793279,4,33,GO:0008360,regulation of cell shape,0.909782609
0,0.032760344,3,9,GO:0050690,regulation of defense response to virus by virus,0.918439716
0,0.032614273,5,7,GO:0018149,peptide cross-linking,0.921071429
0,0.032423006,2,28,GO:0007417,central nervous system development,0.923381295
0,0.03396578,2,9,GO:0031960;GO:0051384,response to corticosteroid,0.926551724
0,0.033316723,2,19,GO:0043200,response to amino acid,0.928169014
0,0.033727639,5,9,GO:0031397;GO:1903321,negative regulation of protein modification by small protein conjugation or removal,0.928472222
0,0.033679899,6,6,GO:0030263,apoptotic chromosome condensation,0.933566434
0,0.03444584,3,13,GO:0071375;GO:1901653,cellular response to peptide,0.935273973
0,0.044620044,2,40,GO:0008038;GO:0008037,cell recognition,0.953551913
0,0.035890034,2,40,GO:0002252,immune effector process,0.954
0,0.035427302,2,16,GO:0030326;GO:0035108,limb morphogenesis,0.954054054
0,0.044446041,3,8,GO:0002028,regulation of sodium ion transport,0.956043956
0,0.035715989,2,10,GO:0048640,negative regulation of developmental growth,0.956375839
0,0.044318033,2,12,GO:0030217,T cell differentiation,0.959944751
0,0.035419752,2,11,GO:0099003,vesicle-mediated transport in synapse,0.960544218
0,0.036463625,1,96,GO:0008283,cell population proliferation,0.963245033
0,0.045725611,6,105,GO:0009150;GO:0006163;GO:0009259;GO:0072521;GO:0019693,purine-containing compound metabolic process,0.963783784
0,0.045329365,2,80,GO:0007267;GO:0023052,signaling,0.964130435
0,0.044291476,3,18,GO:0051650;GO:0051648,vesicle localization,0.965277778
0,0.043642605,2,12,GO:0071345,cellular response to cytokine stimulus,0.966292135
0,0.036895878,2,12,GO:0007204;GO:0051480,regulation of cytosolic calcium ion concentration,0.967105263
0,0.044102606,6,49,GO:0046330;GO:0032874;GO:0070304,positive regulation of stress-activated MAPK cascade,0.967597765
0,0.046178662,2,9,GO:0030521,androgen receptor signaling pathway,0.968817204
0,0.043162314,2,8,GO:0030218,erythrocyte differentiation,0.969886364
0,0.040975372,4,9,GO:0007589,body fluid secretion,0.970958084
0,0.037657895,3,22,GO:1902105,regulation of leukocyte differentiation,0.971428571
0,0.038953181,2,66,GO:0006790,sulfur compound metabolic process,0.972012579
0,0.046664694,4,53,GO:0006869,lipid transport,0.974331551
0,0.037504696,4,249,GO:0065003;GO:0043933,protein-containing complex subunit organization,0.974836601
0,0.038911151,2,89,GO:0002253;GO:0050778,positive regulation of immune response,0.975316456
0,0.043161522,2,9,GO:0044773;GO:0044774,mitotic DNA integrity checkpoint,0.975428571
0,0.040458679,3,5,GO:0006071;GO:0019400,alditol metabolic process,0.975609756
0,0.03966547,6,7,GO:0032869;GO:0046324,cellular response to insulin stimulus,0.975776398
0,0.039951648,3,84,GO:0009152;GO:0006164;GO:0009260;GO:1901293;GO:0009165;GO:0072522;GO:0046390,nucleoside phosphate biosynthetic process,0.976234568
0,0.038686184,2,12,GO:0006750;GO:0019184,nonribosomal peptide biosynthetic process,0.976751592
0,0.040974701,2,35,GO:0043648,dicarboxylic acid metabolic process,0.976807229
0,0.038466577,5,9,GO:0072595,maintenance of protein localization in organelle,0.979166667
0,0.039568831,5,10,GO:0007249,I-kappaB kinase/NF-kappaB signaling,0.979375
0,0.040397946,5,47,GO:0007268;GO:0098916;GO:0099537;GO:0099536,anterograde trans-synaptic signaling,0.980368098
0,0.043124896,5,5,GO:0001885,endothelial cell development,0.98045977
0,0.043124896,3,5,GO:0048259,regulation of receptor-mediated endocytosis,0.98045977
0,0.040845509,5,16,GO:0048675;GO:1990138,axon extension,0.981212121
0,0.041748715,2,11,GO:0048872,homeostasis of number of cells,0.98125
0,0.038416158,2,18,GO:0035113,embryonic appendage morphogenesis,0.984193548
0,0.042798711,2,27,GO:0032088,negative regulation of NF-kappaB transcription factor activity,0.984883721
0,0.042604406,4,17,GO:0002119;GO:0002164,nematode larval development,0.985087719
0,0.042393387,2,27,GO:0045017,glycerolipid biosynthetic process,0.986764706
0,0.047588957,2,5,GO:0045743,positive regulation of fibroblast growth factor receptor signaling pathway,0.987765957
0,0.042255398,4,31,GO:0006446,regulation of translational initiation,0.989349112
0,0.048213857,2,9,GO:0048048,embryonic eye morphogenesis,0.992857143
0,0.049883305,4,12,GO:0048662;GO:0048660,regulation of smooth muscle cell proliferation,0.995595855
0,0.049530865,2,119,GO:0090407,organophosphate biosynthetic process,0.996614583
0,0.050779523,2,66,GO:0090087;GO:0051223;GO:0070201;GO:0032880,regulation of protein localization,0.996683673
0,0.051191798,4,12,GO:0014074;GO:0046683,response to organophosphorus,0.999746193
0,0.049199785,2,54,GO:0001525,angiogenesis,1
0,0.049415235,3,23,GO:0002822;GO:0002819,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1
0,0.050724067,2,6,GO:0048793,pronephros development,1
0,0.050744559,4,141,GO:0051049,regulation of transport,1
0,0.051886827,4,10,GO:0002763;GO:0002761,regulation of myeloid leukocyte differentiation,1
0,0.052895933,5,35,GO:0031175,neuron projection development,1
0,0.052966652,2,50,GO:0046777,protein autophosphorylation,1
0,0.053188693,3,180,GO:0042981;GO:0043067;GO:0010941,regulation of cell death,1
0,0.053675821,4,28,GO:0030182,neuron differentiation,1
0,0.054393336,3,33,GO:0035107,appendage morphogenesis,1
0,0.054629227,2,365,GO:0050793,regulation of developmental process,1
0,0.056196676,2,10,GO:0070979,protein K11-linked ubiquitination,1
0,0.056199177,3,15,GO:1902107,positive regulation of leukocyte differentiation,1
0,0.056407975,3,25,GO:0043523;GO:1901214;GO:0043524;GO:1901215,regulation of neuron apoptotic process,1
0,0.057058439,4,59,GO:0002757;GO:0002764,immune response-activating signal transduction,1
0,0.057334416,2,204,GO:0045595,regulation of cell differentiation,1
0,0.057476366,4,12,GO:0048545,response to steroid hormone,1
0,0.057535819,3,59,GO:0048812;GO:0120039;GO:0048858;GO:0032990,cell part morphogenesis,1
0,0.057607503,2,18,GO:0007088;GO:0051783,regulation of nuclear division,1
0,0.058666932,2,13,GO:0009880,embryonic pattern specification,1
0,0.058792914,3,25,GO:0070663,regulation of leukocyte proliferation,1
0,0.058827702,9,24,GO:0070936,protein K48-linked ubiquitination,1
0,0.058866187,2,29,GO:0048588,developmental cell growth,1
0,0.059139585,3,104,GO:0033043,regulation of organelle organization,1
0,0.059242984,4,113,GO:0050776,regulation of immune response,1
0,0.059888726,2,30,GO:0060560,developmental growth involved in morphogenesis,1
0,0.060294018,4,78,GO:0010243;GO:1901698,response to organonitrogen compound,1
0,0.061804475,2,56,GO:0032147,activation of protein kinase activity,1
0,0.061985317,7,11,GO:0007250;GO:1901224;GO:1901222,activation of NF-kappaB-inducing kinase activity,1
0,0.062766847,2,39,GO:0048638,regulation of developmental growth,1
0,0.063300487,2,16,GO:0006749,glutathione metabolic process,1
0,0.063480853,6,15,GO:0033209,tumor necrosis factor-mediated signaling pathway,1
0,0.063533397,7,74,GO:0043066;GO:0043069;GO:0060548,negative regulation of cell death,1
0,0.063577408,2,34,GO:0051656,establishment of organelle localization,1
0,0.063683013,3,42,GO:0000910,cytokinesis,1
0,0.064018524,4,7,GO:0048170,positive regulation of long-term neuronal synaptic plasticity,1
0,0.064407231,2,35,GO:0009791,post-embryonic development,1
0,0.064629906,2,23,GO:0048562,embryonic organ morphogenesis,1
0,0.064911947,2,22,GO:0006730,one-carbon metabolic process,1
0,0.065065753,6,11,GO:0002706;GO:0002703,regulation of leukocyte mediated immunity,1
0,0.065065753,4,11,GO:0002708;GO:0002709;GO:0002824;GO:0002705;GO:0002821,positive regulation of lymphocyte mediated immunity,1
0,0.065639451,3,473,GO:0006996,organelle organization,1
0,0.065808961,4,6,GO:0000389,mRNA 3'-splice site recognition,1
0,0.065840761,3,11,GO:0006576;GO:0044106;GO:0009308,amine metabolic process,1
0,0.066540596,3,6,GO:0042255,ribosome assembly,1
0,0.06802675,2,18,GO:0031424,keratinization,1
0,0.068198734,5,13,GO:0050885;GO:0050905,neuromuscular process,1
0,0.069300638,2,14,GO:0032868,response to insulin,1
0,0.069702313,3,81,GO:0032989,cellular component morphogenesis,1
0,0.069892037,3,17,GO:0042398,cellular modified amino acid biosynthetic process,1
0,0.071711839,3,9,GO:0048738;GO:0031076,cardiac muscle tissue development,1
0,0.071711839,4,9,GO:0048863,stem cell differentiation,1
0,0.072305125,3,12,GO:0042133,neurotransmitter metabolic process,1
0,0.072617836,3,9,GO:0030858,positive regulation of epithelial cell differentiation,1
0,0.073064997,4,18,GO:0048167,regulation of synaptic plasticity,1
0,0.073075652,5,39,GO:0050807,regulation of synapse organization,1
0,0.073507186,2,12,GO:0006103,2-oxoglutarate metabolic process,1
0,0.073850166,4,12,GO:0045580;GO:0045619,regulation of lymphocyte differentiation,1
0,0.073986661,2,16,GO:0030856,regulation of epithelial cell differentiation,1
0,0.074106455,3,57,GO:0035295;GO:0060429,tube development,1
0,0.074797934,3,41,GO:0051865,protein autoubiquitination,1
0,0.075291521,2,21,GO:0032870,cellular response to hormone stimulus,1
0,0.075955423,2,52,GO:0043123;GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,1
0,0.076095739,2,57,GO:0048589,developmental growth,1
0,0.076573906,3,44,GO:0043433,negative regulation of DNA-binding transcription factor activity,1
0,0.076610343,3,18,GO:0050880;GO:0035150;GO:0003018,regulation of tube size,1
0,0.077207598,2,25,GO:0070534,protein K63-linked ubiquitination,1
0,0.077378095,3,111,GO:0044087,regulation of cellular component biogenesis,1
0,0.078145056,3,65,GO:0042493,response to drug,1
0,0.079135069,5,9,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,1
0,0.079495028,4,6,GO:0008582;GO:1904396,regulation of synaptic growth at neuromuscular junction,1
0,0.080344521,5,18,GO:0030261;GO:0006323,chromosome condensation,1
0,0.080446497,2,39,GO:0006112;GO:0015980,energy derivation by oxidation of organic compounds,1
0,0.081413804,4,355,GO:0016192,vesicle-mediated transport,1
0,0.082163829,3,47,GO:0001101,response to acid chemical,1
0,0.083418944,2,24,GO:0007005,mitochondrion organization,1
0,0.083434117,3,19,GO:0003013,circulatory system process,1
0,0.084115402,2,26,GO:0009755,hormone-mediated signaling pathway,1
0,0.084315379,4,11,GO:0001570,vasculogenesis,1
0,0.084315379,2,11,GO:0010001,glial cell differentiation,1
0,0.08536288,6,126,GO:0050767;GO:0051960;GO:0060284,regulation of nervous system development,1
0,0.085591876,3,61,GO:0010564,regulation of cell cycle process,1
0,0.086026789,3,30,GO:0019221,cytokine-mediated signaling pathway,1
0,0.086862402,3,12,GO:0030183,B cell differentiation,1
0,0.087453711,2,294,GO:0009967;GO:0010647;GO:0023056;GO:0048584,positive regulation of response to stimulus,1
0,0.087824571,2,13,GO:0009411,response to UV,1
0,0.087946311,4,9,GO:0045124;GO:0046850;GO:0034103,regulation of bone resorption,1
0,0.087978197,5,12,GO:0000186,activation of MAPKK activity,1
0,0.088889557,2,28,GO:0009416,response to light stimulus,1
0,0.090086435,2,25,GO:0006914;GO:0061919,autophagy,1
0,0.090234085,2,12,GO:0002064,epithelial cell development,1
0,0.090234085,4,12,GO:0007368;GO:0009855;GO:0009799,determination of bilateral symmetry,1
0,0.090234085,6,12,GO:0045747,positive regulation of Notch signaling pathway,1
0,0.091088652,2,47,GO:0098542,defense response to other organism,1
0,0.091191612,3,49,GO:0050769;GO:0010720;GO:0051962,positive regulation of nervous system development,1
0,0.091876413,2,81,GO:0000226,microtubule cytoskeleton organization,1
0,0.092353141,2,22,GO:0044089,positive regulation of cellular component biogenesis,1
0,0.093019233,4,31,GO:0034097,response to cytokine,1
0,0.094118825,2,302,GO:0042221,response to chemical,1
0,0.094658257,2,202,GO:0032270;GO:0051247,positive regulation of protein metabolic process,1
0,0.094782264,3,32,GO:0008654,phospholipid biosynthetic process,1
0,0.095854929,3,68,GO:0043406;GO:0043405;GO:0071902,regulation of MAP kinase activity,1
0,0.097154572,3,25,GO:0043434;GO:1901652,response to peptide,1
0,0.097205261,2,55,GO:0006366,transcription by RNA polymerase II,1
0,0.097569343,5,14,GO:0006302,double-strand break repair,1
0,0.097997374,2,61,GO:0051046;GO:1903530,regulation of secretion,1
0,0.098265373,5,14,GO:0048639,positive regulation of developmental growth,1
0,0.098271301,4,17,GO:0046474,glycerophospholipid biosynthetic process,1
0,0.098486297,2,138,GO:0006520,cellular amino acid metabolic process,1
0,0.098538275,4,25,GO:0030099,myeloid cell differentiation,1
0,0.099000276,5,68,GO:0006310,DNA recombination,1
0,0.099340628,2,69,GO:0051188,cofactor biosynthetic process,1
0,0.100816722,2,128,GO:0009628,response to abiotic stimulus,1
0,0.102510253,3,81,GO:0006631,fatty acid metabolic process,1
0,0.102664596,2,196,GO:0048646,anatomical structure formation involved in morphogenesis,1
0,0.103403102,2,11,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,1
0,0.103403102,6,11,GO:0032715,negative regulation of interleukin-6 production,1
0,0.104052853,2,6,GO:0051156,glucose 6-phosphate metabolic process,1
0,0.104171024,4,15,GO:0002460;GO:0002250;GO:0042108;GO:0042088;GO:0045410;GO:0032755;GO:0045408,positive regulation of cytokine biosynthetic process,1
0,0.105210027,3,19,GO:0050728;GO:0031348;GO:0050727,regulation of inflammatory response,1
0,0.106410505,2,80,GO:0051493;GO:0032956;GO:0032970,regulation of cytoskeleton organization,1
0,0.106462208,2,31,GO:0030522,intracellular receptor signaling pathway,1
0,0.106579738,4,15,GO:0014014;GO:0014013;GO:0045685,regulation of gliogenesis,1
0,0.106658669,2,34,GO:0006575,cellular modified amino acid metabolic process,1
0,0.107345716,5,15,GO:0007093,mitotic cell cycle checkpoint,1
0,0.107985509,2,29,GO:0001505,regulation of neurotransmitter levels,1
0,0.108158792,2,42,GO:0046486,glycerolipid metabolic process,1
0,0.108827981,2,64,GO:0035023,regulation of Rho protein signal transduction,1
0,0.109098349,2,5,GO:0097039,protein linear polyubiquitination,1
0,0.110439282,2,15,GO:0040014,regulation of multicellular organism growth,1
0,0.11148812,3,21,GO:0030098,lymphocyte differentiation,1
0,0.111742644,3,15,GO:0002699,positive regulation of immune effector process,1
0,0.111835307,2,48,GO:0051249;GO:0002694;GO:0050865,regulation of cell activation,1
0,0.114627558,2,38,GO:0071417;GO:1901699,cellular response to organonitrogen compound,1
0,0.116164511,3,803,GO:0048519;GO:0048523,negative regulation of biological process,1
0,0.116478194,2,32,GO:0007059,chromosome segregation,1
0,0.117117278,3,24,GO:0045639;GO:0045637;GO:1903708,positive regulation of hemopoiesis,1
0,0.117367045,2,8,GO:0032012,regulation of ARF protein signal transduction,1
0,0.117406877,2,66,GO:0009725,response to hormone,1
0,0.117612307,2,15,GO:0048169;GO:0048168,regulation of neuronal synaptic plasticity,1
0,0.117612307,2,15,GO:0050806,positive regulation of synaptic transmission,1
0,0.119189521,2,23,GO:0032675,regulation of interleukin-6 production,1
0,0.119374201,2,21,GO:0008063;GO:0034142,toll-like receptor 4 signaling pathway,1
0,0.119538334,4,22,GO:0042110,T cell activation,1
0,0.119996286,2,414,GO:0051641;GO:0046907;GO:0051649,cellular localization,1
0,0.120011391,2,6,GO:0050707,regulation of cytokine secretion,1
0,0.120837753,2,16,GO:1903707,negative regulation of hemopoiesis,1
0,0.121003953,3,18,GO:0001708,cell fate specification,1
0,0.121648416,2,20,GO:0019751,polyol metabolic process,1
0,0.121682738,2,6,GO:0008535,respiratory chain complex IV assembly,1
0,0.122801826,3,141,GO:1902533,positive regulation of intracellular signal transduction,1
0,0.123887846,3,193,GO:0019637,organophosphate metabolic process,1
0,0.124302234,2,14,GO:0070536,protein K63-linked deubiquitination,1
0,0.12604907,6,31,GO:1901990;GO:1901987,regulation of mitotic cell cycle phase transition,1
0,0.128810566,2,33,GO:0048534,hematopoietic or lymphoid organ development,1
0,0.128902925,3,18,GO:0032507;GO:0051651,maintenance of location in cell,1
0,0.129592105,2,38,GO:1903706,regulation of hemopoiesis,1
0,0.129665018,2,20,GO:0030100,regulation of endocytosis,1
0,0.12966746,2,16,GO:1905952,regulation of lipid localization,1
0,0.129903276,4,5,GO:0000050;GO:0019627;GO:0071941,urea metabolic process,1
0,0.129903276,4,5,GO:1901654,response to ketone,1
0,0.129968717,3,6,GO:0032456,endocytic recycling,1
0,0.13039595,2,187,GO:0044255,cellular lipid metabolic process,1
0,0.130534496,3,5,GO:0021766,hippocampus development,1
0,0.130534594,3,140,GO:0009117;GO:0006753;GO:0055086,nucleobase-containing small molecule metabolic process,1
0,0.131499204,3,14,GO:0006376,mRNA splice site selection,1
0,0.132122053,2,142,GO:0030030,cell projection organization,1
0,0.13249013,4,22,GO:0042113,B cell activation,1
0,0.132635844,4,36,GO:0002683,negative regulation of immune system process,1
0,0.133496769,5,16,GO:0048592;GO:0090596,sensory organ morphogenesis,1
0,0.134349803,2,25,GO:1903046,meiotic cell cycle process,1
0,0.136851788,3,16,GO:0032720;GO:0032680;GO:1903556;GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,1
0,0.136969928,2,39,GO:0009108,coenzyme biosynthetic process,1
0,0.138084004,2,6,GO:0001942,hair follicle development,1
0,0.138084004,3,6,GO:0043588,skin development,1
0,0.140247675,4,83,GO:0046328;GO:0032872;GO:0070302;GO:0080135,regulation of cellular response to stress,1
0,0.14126688,2,6,GO:0009913,epidermal cell differentiation,1
0,0.14162647,1,82,GO:0040007,growth,1
0,0.142357254,2,10,GO:0045075;GO:0032655,regulation of interleukin-12 production,1
0,0.146283521,6,20,GO:0043010,camera-type eye development,1
0,0.147696377,5,90,GO:0071900,regulation of protein serine/threonine kinase activity,1
0,0.148397411,4,18,GO:0061041;GO:1903034,regulation of wound healing,1
0,0.149789605,2,6,GO:0050974;GO:0050982,detection of mechanical stimulus,1
0,0.151013086,2,21,GO:0007626,locomotory behavior,1
0,0.151706141,5,26,GO:0008593,regulation of Notch signaling pathway,1
0,0.152451085,3,5,GO:0019915,lipid storage,1
0,0.152451085,7,5,GO:0045582;GO:0045621,positive regulation of lymphocyte differentiation,1
0,0.153093865,3,92,GO:0090066;GO:0032535,regulation of anatomical structure size,1
0,0.154481535,2,70,GO:0043254;GO:0030833;GO:0008064;GO:0032271;GO:0030832;GO:0110053;GO:1902903,regulation of protein complex assembly,1
0,0.158005757,2,5,GO:0070207,protein homotrimerization,1
0,0.158301476,2,242,GO:1901566,organonitrogen compound biosynthetic process,1
0,0.158846649,2,14,GO:0008088,axo-dendritic transport,1
0,0.158846649,3,14,GO:1905809,negative regulation of synapse organization,1
0,0.159271937,4,19,GO:0042129;GO:0050670;GO:0032944,regulation of lymphocyte proliferation,1
0,0.160757452,2,6,GO:0051053,negative regulation of DNA metabolic process,1
0,0.161067975,2,36,GO:0045666;GO:0010976;GO:0031346,positive regulation of neuron differentiation,1
0,0.161171013,3,53,GO:0022618;GO:0071826,ribonucleoprotein complex subunit organization,1
0,0.162181549,2,5,GO:1903409,reactive oxygen species biosynthetic process,1
0,0.162522895,2,632,GO:0009966;GO:0010646;GO:0023051;GO:0048583,regulation of response to stimulus,1
0,0.163615512,3,30,GO:0048568,embryonic organ development,1
0,0.164115495,2,5,GO:0010172,embryonic body morphogenesis,1
0,0.165186245,2,14,GO:0032606,type I interferon production,1
0,0.165589552,3,5,GO:0006488;GO:0006490,oligosaccharide-lipid intermediate biosynthetic process,1
0,0.16631315,2,166,GO:0051726,regulation of cell cycle,1
0,0.166406073,3,75,GO:0030162,regulation of proteolysis,1
0,0.167566753,2,589,GO:0065008,regulation of biological quality,1
0,0.167568798,2,36,GO:0016197,endosomal transport,1
0,0.168529854,3,19,GO:0030518;GO:0043401,steroid hormone mediated signaling pathway,1
0,0.170174305,2,11,GO:0007623,circadian rhythm,1
0,0.170303226,7,113,GO:0046578;GO:0051056,regulation of small GTPase mediated signal transduction,1
0,0.170894489,3,97,GO:0010975;GO:0045664;GO:0120035;GO:0031344,regulation of neuron differentiation,1
0,0.171313377,2,71,GO:0006732,coenzyme metabolic process,1
0,0.171314899,2,7,GO:0050906,detection of stimulus involved in sensory perception,1
0,0.171314899,3,7,GO:0051924,regulation of calcium ion transport,1
0,0.171580281,4,54,GO:0001558,regulation of cell growth,1
0,0.172030623,2,9,GO:0017004,cytochrome complex assembly,1
0,0.172461809,8,20,GO:0050856;GO:0050854;GO:0046637;GO:0046634;GO:0046006;GO:0033962;GO:0046007;GO:0042130;GO:0050672;GO:0050868;GO:0032945;GO:1903038;GO:0022408;GO:0030889;GO:0030888;GO:0002635;GO:0002823;GO:0002820;GO:0045623;GO:0043371;GO:0045622;GO:0043370;GO:0046639;GO:2000515;GO:2000514;GO:0045581;GO:0046636;GO:0045620;GO:1902106,regulation of alpha-beta T cell differentiation,1
0,0.172822046,2,88,GO:0022900,electron transport chain,1
0,0.172960415,7,11,GO:0006739,NADP metabolic process,1
0,0.173070573,2,47,GO:0043065;GO:0043068;GO:0010942,positive regulation of programmed cell death,1
0,0.173698619,4,15,GO:0002756;GO:0034138,toll-like receptor 3 signaling pathway,1
0,0.174166095,2,5,GO:0006654;GO:0046473,phosphatidic acid biosynthetic process,1
0,0.174166095,2,5,GO:0046464;GO:0046461;GO:0046503,acylglycerol catabolic process,1
0,0.17475096,3,7,GO:0009410,response to xenobiotic stimulus,1
0,0.17475096,2,7,GO:0048565,digestive tract development,1
0,0.175789402,3,6,GO:0032374;GO:0032371;GO:0032368,regulation of lipid transport,1
0,0.176201908,2,57,GO:0006644,phospholipid metabolic process,1
0,0.17632006,3,5,GO:0090277;GO:0046887,positive regulation of hormone secretion,1
0,0.176433452,2,89,GO:0022412,cellular process involved in reproduction in multicellular organism,1
0,0.176476831,6,96,GO:0045860;GO:0033674;GO:0051347,positive regulation of transferase activity,1
0,0.178579374,3,365,GO:0032268;GO:0051246,regulation of protein metabolic process,1
0,0.179247754,5,34,GO:0006874;GO:0055074;GO:0072503;GO:0072507,divalent inorganic cation homeostasis,1
0,0.179314961,2,6,GO:0006105,succinate metabolic process,1
0,0.180452076,2,6,GO:0051457,maintenance of protein location in nucleus,1
0,0.180607614,4,7,GO:0032490;GO:0098581;GO:0009595,detection of external biotic stimulus,1
0,0.18212173,3,6,GO:0046580;GO:0051058,negative regulation of Ras protein signal transduction,1
0,0.182219622,3,38,GO:0035239,tube morphogenesis,1
0,0.182344107,2,43,GO:0016049,cell growth,1
0,0.18241084,2,300,GO:0006915;GO:0012501;GO:0008219,cell death,1
0,0.185058739,2,30,GO:0032102,negative regulation of response to external stimulus,1
0,0.185848439,-1,6,GO:0008633,obsolete activation of pro-apoptotic gene products,1
0,0.186361427,6,6,GO:0007095;GO:0044818;GO:0010972;GO:1902750,mitotic G2/M transition checkpoint,1
0,0.186361427,2,6,GO:0048190;GO:0007450;GO:0035222;GO:0007447,wing disc pattern formation,1
0,0.186711006,3,207,GO:0050790,regulation of catalytic activity,1
0,0.187729104,2,69,GO:0051130,positive regulation of cellular component organization,1
0,0.188108299,2,62,GO:0051276,chromosome organization,1
0,0.189325401,2,41,GO:0031400,negative regulation of protein modification process,1
0,0.189380075,2,51,GO:0044262,cellular carbohydrate metabolic process,1
0,0.190612903,3,114,GO:0043410;GO:0043408,regulation of MAPK cascade,1
0,0.191090077,2,80,GO:0032269;GO:0051248,negative regulation of protein metabolic process,1
0,0.191659921,5,7,GO:0050771,negative regulation of axonogenesis,1
0,0.193034792,2,6,GO:0072132,mesenchyme morphogenesis,1
0,0.193903151,2,29,GO:0071103,DNA conformation change,1
0,0.19408449,3,9,GO:0043542,endothelial cell migration,1
0,0.19435843,3,43,GO:0001822,kidney development,1
0,0.195091326,2,79,GO:0022604,regulation of cell morphogenesis,1
0,0.195129712,2,160,GO:0005975,carbohydrate metabolic process,1
0,0.195218135,3,9,GO:0022405;GO:0022404,hair cycle process,1
0,0.195658472,2,231,GO:0007010,cytoskeleton organization,1
0,0.195812335,4,8,GO:0055081,anion homeostasis,1
0,0.196465751,2,27,GO:0006650,glycerophospholipid metabolic process,1
0,0.196579023,3,21,GO:0070507,regulation of microtubule cytoskeleton organization,1
0,0.19731333,2,246,GO:0032879,regulation of localization,1
0,0.201050958,4,7,GO:0032008,positive regulation of TOR signaling,1
0,0.201814903,5,56,GO:0007050,cell cycle arrest,1
0,0.202326658,3,6,GO:0007269,neurotransmitter secretion,1
0,0.202646516,2,17,GO:0006957;GO:0006956,complement activation,1
0,0.205083152,3,7,GO:0009081,branched-chain amino acid metabolic process,1
0,0.20582369,2,124,GO:0007049,cell cycle,1
0,0.205908688,3,76,GO:0006066,alcohol metabolic process,1
0,0.206978568,2,51,GO:0006892,post-Golgi vesicle-mediated transport,1
0,0.20745762,4,39,GO:0060627,regulation of vesicle-mediated transport,1
0,0.207629651,4,33,GO:0002521,leukocyte differentiation,1
0,0.208293265,2,7,GO:0006626,protein targeting to mitochondrion,1
0,0.209013799,5,10,GO:0000723;GO:0032200,telomere maintenance,1
0,0.211421816,5,292,GO:1902531,regulation of intracellular signal transduction,1
0,0.211736049,2,379,GO:0007155;GO:0022610,cell adhesion,1
0,0.211779994,4,30,GO:0009952,anterior/posterior pattern specification,1
0,0.214447402,2,373,GO:0022607,cellular component assembly,1
0,0.216014497,3,9,GO:0010043,response to zinc ion,1
0,0.216644396,4,155,GO:0001934;GO:0031401;GO:0042327;GO:0045937;GO:0010562,positive regulation of protein modification process,1
0,0.217131967,2,219,GO:0010033,response to organic substance,1
0,0.217597692,2,146,GO:0016567;GO:0032446,protein modification by small protein conjugation,1
0,0.217633973,2,10,GO:0002065,columnar/cuboidal epithelial cell differentiation,1
0,0.219335497,3,78,GO:0120036,plasma membrane bounded cell projection organization,1
0,0.220774572,2,7,GO:0035050;GO:0008078,embryonic heart tube development,1
0,0.220800675,3,167,GO:0009968;GO:0010648;GO:0023057;GO:0048585,negative regulation of response to stimulus,1
0,0.22237751,2,55,GO:0071495,cellular response to endogenous stimulus,1
0,0.223244712,2,23,GO:0090276;GO:0046883,regulation of hormone secretion,1
0,0.224371101,9,26,GO:0006919;GO:0043280;GO:0043281;GO:2001056;GO:2000116;GO:0010950;GO:0052548;GO:0010952;GO:0052547,regulation of endopeptidase activity,1
0,0.225231186,4,108,GO:0006518,peptide metabolic process,1
0,0.225282068,3,8,GO:0007040;GO:0080171,lytic vacuole organization,1
0,0.225823713,7,39,GO:0016579;GO:0070646,protein modification by small protein removal,1
0,0.225860836,3,81,GO:0044092,negative regulation of molecular function,1
0,0.227273031,7,9,GO:0090329,regulation of DNA-dependent DNA replication,1
0,0.227568461,6,8,GO:0045736;GO:1904030,negative regulation of cyclin-dependent protein kinase activity,1
0,0.227599089,2,41,GO:0044242,cellular lipid catabolic process,1
0,0.229837586,5,7,GO:0006265,DNA topological change,1
0,0.229983857,2,102,GO:0009719,response to endogenous stimulus,1
0,0.230133147,2,246,GO:0006357,regulation of transcription by RNA polymerase II,1
0,0.230763975,6,10,GO:0009187,cyclic nucleotide metabolic process,1
0,0.231257496,5,8,GO:0042771;GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,1
0,0.231285343,4,59,GO:0007156;GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,1
0,0.232580952,4,25,GO:0010970;GO:0030705;GO:0099111,transport along microtubule,1
0,0.232940387,3,43,GO:0050804;GO:0099177,modulation of chemical synaptic transmission,1
0,0.233397233,2,8,GO:0051646,mitochondrion localization,1
0,0.233725758,3,147,GO:0051186,cofactor metabolic process,1
0,0.234295033,3,7,GO:0010891;GO:0010889;GO:0010898;GO:0010896;GO:0050996,positive regulation of lipid catabolic process,1
0,0.23550753,3,138,GO:0016055;GO:1905114,cell surface receptor signaling pathway involved in cell-cell signaling,1
0,0.236093988,2,108,GO:0045786,negative regulation of cell cycle,1
0,0.236428874,2,211,GO:0042127,regulation of cell population proliferation,1
0,0.236653656,5,42,GO:0019216,regulation of lipid metabolic process,1
0,0.236916132,2,9,GO:0030516;GO:0061387,regulation of extent of cell growth,1
0,0.239195247,2,70,GO:0098609,cell-cell adhesion,1
0,0.23947018,5,7,GO:0019227;GO:0098870,neuronal action potential propagation,1
0,0.242597063,2,37,GO:1901607;GO:0008652,cellular amino acid biosynthetic process,1
0,0.24605693,5,488,GO:0010604;GO:0009893;GO:0031325;GO:0051173,positive regulation of metabolic process,1
0,0.246656365,2,64,GO:0043161;GO:0010498,proteasome-mediated ubiquitin-dependent protein catabolic process,1
0,0.246943413,2,19,GO:0022613;GO:0044085;GO:0042254,cellular component biogenesis,1
0,0.247243499,2,26,GO:0001816,cytokine production,1
0,0.247336261,3,987,GO:0034654;GO:0018130;GO:0019438;GO:1901362;GO:0034645;GO:0009059,organic cyclic compound biosynthetic process,1
0,0.248278495,3,353,GO:0030154,cell differentiation,1
0,0.248985698,3,11,GO:0031214,biomineral tissue development,1
0,0.249236784,3,305,GO:0019752;GO:0043436;GO:0006082,organic acid metabolic process,1
0,0.249385266,2,27,GO:0071229,cellular response to acid chemical,1
0,0.249604766,2,8,GO:0006040,amino sugar metabolic process,1
0,0.250783717,4,44,GO:0050870;GO:0050863;GO:0051251;GO:1903039;GO:0002696;GO:0022409;GO:1903037;GO:0022407;GO:0045785;GO:0050867,regulation of cell-cell adhesion,1
0,0.251046936,2,9,GO:0000819,sister chromatid segregation,1
0,0.25350896,2,9,GO:0045648;GO:0045646,regulation of erythrocyte differentiation,1
0,0.253635769,2,60,GO:1901701,cellular response to oxygen-containing compound,1
0,0.25439669,4,56,GO:0014070,response to organic cyclic compound,1
0,0.25498295,2,69,GO:0009792,embryo development ending in birth or egg hatching,1
0,0.25516129,2,112,GO:0009888,tissue development,1
0,0.255219832,6,8,GO:0045739;GO:0006282;GO:2001022,regulation of DNA repair,1
0,0.256627751,2,139,GO:0051301,cell division,1
0,0.256851718,4,346,GO:0006796;GO:0006793,phosphorus metabolic process,1
0,0.257477069,2,9,GO:0007006,mitochondrial membrane organization,1
0,0.258058313,4,13,GO:0061001;GO:0060998;GO:0099175,regulation of dendritic spine development,1
0,0.258149425,2,101,GO:0048468,cell development,1
0,0.260023388,2,126,GO:0007154,cell communication,1
0,0.262637033,2,585,GO:0044281,small molecule metabolic process,1
0,0.263470998,7,9,GO:0010389;GO:1902749,regulation of G2/M transition of mitotic cell cycle,1
0,0.265141934,3,110,GO:0070887;GO:0071310,cellular response to chemical stimulus,1
0,0.266463803,5,12,GO:0021953,central nervous system neuron differentiation,1
0,0.270818935,3,10,GO:0042632;GO:0055092,cholesterol homeostasis,1
0,0.273129023,3,12,GO:0019933;GO:0019935,cAMP-mediated signaling,1
0,0.274248803,3,87,GO:0030163,protein catabolic process,1
0,0.275464097,3,88,GO:0048598,embryonic morphogenesis,1
0,0.275918909,2,14,GO:0008033,tRNA processing,1
0,0.275918909,2,14,GO:0009451,RNA modification,1
0,0.27727424,2,34,GO:0031396;GO:1903320,regulation of protein modification by small protein conjugation or removal,1
0,0.279995164,3,29,GO:0006959,humoral immune response,1
0,0.28057444,2,10,GO:0072655;GO:0070585,establishment of protein localization to mitochondrion,1
0,0.283228555,3,13,GO:0009612,response to mechanical stimulus,1
0,0.28391121,2,39,GO:1902532,negative regulation of intracellular signal transduction,1
0,0.284133398,2,40,GO:0045765;GO:1901342,regulation of vasculature development,1
0,0.285461489,3,90,GO:0009887,animal organ morphogenesis,1
0,0.28604206,2,9,GO:0006471,protein ADP-ribosylation,1
0,0.288909268,4,13,GO:0071364;GO:0070849;GO:0071363;GO:0070848,response to growth factor,1
0,0.289618574,5,9,GO:0050994,regulation of lipid catabolic process,1
0,0.290079263,3,35,GO:0045732,positive regulation of protein catabolic process,1
0,0.292005962,5,55,GO:0006875;GO:0055065,metal ion homeostasis,1
0,0.292428874,6,10,GO:0050709;GO:0002792;GO:0051224;GO:1904950,negative regulation of protein transport,1
0,0.293854652,3,93,GO:0000209,protein polyubiquitination,1
0,0.294689508,3,694,GO:0015031;GO:0015833;GO:0045184;GO:0042886;GO:0071702;GO:0008104;GO:0071705;GO:0033036,organic substance transport,1
0,0.296305344,2,155,GO:0048731,system development,1
0,0.297369914,2,24,GO:0006081,cellular aldehyde metabolic process,1
0,0.297386966,4,10,GO:0009948,anterior/posterior axis specification,1
0,0.297386966,3,10,GO:0010171,body morphogenesis,1
0,0.298063813,2,11,GO:0042180,cellular ketone metabolic process,1
0,0.302882643,3,50,GO:0050878,regulation of body fluid levels,1
0,0.303299424,3,91,GO:0031329;GO:0009894,regulation of catabolic process,1
0,0.303364367,2,33,GO:0032496;GO:0002237,response to molecule of bacterial origin,1
0,0.305312231,2,14,GO:0071407,cellular response to organic cyclic compound,1
0,0.306687407,2,15,GO:0006635,fatty acid beta-oxidation,1
0,0.308272246,5,14,GO:0017157,regulation of exocytosis,1
0,0.308923997,6,11,GO:0002702,positive regulation of production of molecular mediator of immune response,1
0,0.309466591,2,12,GO:0002698,negative regulation of immune effector process,1
0,0.310131828,2,10,GO:0051017;GO:0061572,actin filament bundle assembly,1
0,0.311225163,2,34,GO:0051606,detection of stimulus,1
0,0.312990893,2,452,GO:0006508,proteolysis,1
0,0.313217372,4,19,GO:0030433;GO:0036503,ERAD pathway,1
0,0.313524454,2,60,GO:0019318;GO:0005996,monosaccharide metabolic process,1
0,0.314519856,2,168,GO:0055114;GO:0006091,oxidation-reduction process,1
0,0.314732977,3,15,GO:0008361,regulation of cell size,1
0,0.314732977,3,15,GO:0009581;GO:0009582,detection of abiotic stimulus,1
0,0.315599248,2,10,GO:0010888;GO:0010883;GO:1905953,regulation of lipid storage,1
0,0.31596156,2,52,GO:0006486;GO:0043413;GO:0070085,protein glycosylation,1
0,0.316057562,2,10,GO:0030149;GO:0046466,membrane lipid catabolic process,1
0,0.316472942,4,31,GO:1901991;GO:1901988;GO:0045930;GO:0010948,negative regulation of cell cycle process,1
0,0.316610978,3,101,GO:0008284,positive regulation of cell population proliferation,1
0,0.316864052,4,51,GO:0045862,positive regulation of proteolysis,1
0,0.318987065,2,12,GO:0032103,positive regulation of response to external stimulus,1
0,0.318987065,7,12,GO:0042102;GO:0050671;GO:0032946;GO:0070665,positive regulation of mononuclear cell proliferation,1
0,0.321009902,4,12,GO:0045727;GO:0034250,positive regulation of cellular amide metabolic process,1
0,0.321009902,2,12,GO:0051101,regulation of DNA binding,1
0,0.321009902,4,12,GO:0097193;GO:0097190;GO:0008630,apoptotic signaling pathway,1
0,0.32134897,5,54,GO:0042176,regulation of protein catabolic process,1
0,0.324879137,2,179,GO:0007017,microtubule-based process,1
0,0.325256701,2,109,GO:0008610,lipid biosynthetic process,1
0,0.325856458,2,139,GO:0045859;GO:0043549;GO:0051338,regulation of transferase activity,1
0,0.326802504,4,64,GO:0030003;GO:0006873;GO:0055082,cellular chemical homeostasis,1
0,0.327839426,4,11,GO:0007369,gastrulation,1
0,0.329083417,3,51,GO:0046649;GO:0045321,leukocyte activation,1
0,0.329527233,2,16,GO:0097164,ammonium ion metabolic process,1
0,0.330609604,3,12,GO:0070206,protein trimerization,1
0,0.331034463,5,11,GO:2001020,regulation of response to DNA damage stimulus,1
0,0.331396391,2,61,GO:0006979,response to oxidative stress,1
0,0.331522169,3,12,GO:0001709,cell fate determination,1
0,0.331805187,3,15,GO:0002755;GO:0034130;GO:0034134,MyD88-dependent toll-like receptor signaling pathway,1
0,0.331805187,2,15,GO:0071219;GO:0071216,cellular response to biotic stimulus,1
0,0.331858247,7,235,GO:0001932;GO:0031399;GO:0042325;GO:0019220;GO:0051174,regulation of protein modification process,1
0,0.332273053,2,120,GO:0032787,monocarboxylic acid metabolic process,1
0,0.334620643,1,11,GO:0000003,reproduction,1
0,0.334854345,2,14,GO:0030336;GO:2000146;GO:0051271,negative regulation of cellular component movement,1
0,0.334854345,2,14,GO:0048705,skeletal system morphogenesis,1
0,0.337446807,2,179,GO:0070647,protein modification by small protein conjugation or removal,1
0,0.337668432,3,12,GO:1903531;GO:0051048,negative regulation of secretion by cell,1
0,0.337967741,3,13,GO:0016525;GO:2000181;GO:1901343,negative regulation of vasculature development,1
0,0.338752051,2,54,GO:0031331;GO:0009896,positive regulation of catabolic process,1
0,0.341595529,3,221,GO:0042592,homeostatic process,1
0,0.343393555,4,12,GO:0045176,apical protein localization,1
0,0.347612445,2,14,GO:0043488;GO:0043487;GO:0061013,regulation of mRNA catabolic process,1
0,0.347762549,2,44,GO:0006887,exocytosis,1
0,0.348876121,5,20,GO:0048814;GO:0050773,regulation of dendrite development,1
0,0.351038944,5,37,GO:0051345,positive regulation of hydrolase activity,1
0,0.351261685,2,14,GO:0032006,regulation of TOR signaling,1
0,0.351261685,2,14,GO:0071230,cellular response to amino acid stimulus,1
0,0.352169002,2,152,GO:0043603,cellular amide metabolic process,1
0,0.352315015,4,17,GO:0050796,regulation of insulin secretion,1
0,0.354041187,2,62,GO:0045454,cell redox homeostasis,1
0,0.354055806,2,103,GO:0007018,microtubule-based movement,1
0,0.354826649,2,14,GO:0098813,nuclear chromosome segregation,1
0,0.356305182,6,34,GO:0046496;GO:0019362;GO:0006733;GO:0072524,pyridine-containing compound metabolic process,1
0,0.356392613,2,79,GO:0055080;GO:0098771;GO:0050801,ion homeostasis,1
0,0.359923046,6,12,GO:0099643,signal release from synapse,1
0,0.360818744,2,129,GO:1901700,response to oxygen-containing compound,1
0,0.362361831,3,17,GO:0009593,detection of chemical stimulus,1
0,0.364495017,3,18,GO:0031669;GO:0031668;GO:0009267;GO:0042594,cellular response to nutrient levels,1
0,0.364952544,3,12,GO:0009395,phospholipid catabolic process,1
0,0.364952544,2,12,GO:1903509;GO:0006664,liposaccharide metabolic process,1
0,0.364998395,2,13,GO:0030032;GO:0097581,lamellipodium assembly,1
0,0.365926073,5,123,GO:0018193,peptidyl-amino acid modification,1
0,0.366098504,4,33,GO:0032886,regulation of microtubule-based process,1
0,0.366334533,1,42,GO:0048511,rhythmic process,1
0,0.367191543,5,92,GO:0043043;GO:0043604,amide biosynthetic process,1
0,0.368661243,4,16,GO:0010771;GO:0010977;GO:0031345,negative regulation of neuron projection development,1
0,0.368661243,2,16,GO:0040013,negative regulation of locomotion,1
0,0.369362894,3,15,GO:0055088,lipid homeostasis,1
0,0.372472769,2,12,GO:0001508,action potential,1
0,0.372496573,2,22,GO:0010631,epithelial cell migration,1
0,0.374777671,2,104,GO:0048609;GO:0007276,multicellular organismal reproductive process,1
0,0.375737968,2,275,GO:0009653,anatomical structure morphogenesis,1
0,0.377184432,3,63,GO:0003002,regionalization,1
0,0.380831144,2,55,GO:0070925,organelle assembly,1
0,0.381892809,2,82,GO:0051129,negative regulation of cellular component organization,1
0,0.384026792,2,112,GO:1901615,organic hydroxy compound metabolic process,1
0,0.385998438,3,82,GO:0032940;GO:0046903,secretion,1
0,0.387193327,2,54,GO:0051961;GO:0050768;GO:0010721,negative regulation of nervous system development,1
0,0.38735127,2,13,GO:0090208;GO:0090207,regulation of triglyceride metabolic process,1
0,0.388170084,2,108,GO:0008285,negative regulation of cell population proliferation,1
0,0.394481066,2,16,GO:0022602,ovulation cycle process,1
0,0.394481066,2,16,GO:0034754,cellular hormone metabolic process,1
0,0.395476684,2,43,GO:0001654;GO:0007423,sensory organ development,1
0,0.397165646,3,49,GO:0016032;GO:0044403,symbiont process,1
0,0.397396038,2,96,GO:0006417;GO:0010608;GO:0034248,posttranscriptional regulation of gene expression,1
0,0.398447782,2,359,GO:0007275,multicellular organism development,1
0,0.398999847,5,316,GO:0045893;GO:0010628;GO:1903508;GO:1902680;GO:0010557;GO:0031328;GO:0051254;GO:0009891;GO:0045935,positive regulation of biosynthetic process,1
0,0.399763677,2,18,GO:0050920,regulation of chemotaxis,1
0,0.401292552,2,35,GO:0061136;GO:1903050;GO:1903362,regulation of cellular protein catabolic process,1
0,0.401728775,8,53,GO:0006364;GO:0016072,rRNA metabolic process,1
0,0.403378305,2,17,GO:0007033,vacuole organization,1
0,0.403378305,3,17,GO:0043112;GO:0001919,receptor metabolic process,1
0,0.405598339,3,15,GO:0001843;GO:0060606,neural tube closure,1
0,0.40949678,4,165,GO:0022603,regulation of anatomical structure morphogenesis,1
0,0.414585729,2,22,GO:0009636,response to toxic substance,1
0,0.414585729,5,22,GO:0071396,cellular response to lipid,1
0,0.416600265,2,22,GO:0060341,regulation of cellular localization,1
0,0.418656146,2,516,GO:0048869,cellular developmental process,1
0,0.419344819,4,41,GO:0051693;GO:0030835;GO:0030837;GO:0030834;GO:0051494;GO:1901880;GO:1902904;GO:0032272;GO:0031333;GO:1901879;GO:0043242;GO:0043244,regulation of protein complex disassembly,1
0,0.420927876,3,38,GO:0051052,regulation of DNA metabolic process,1
0,0.425122101,2,15,GO:0006836,neurotransmitter transport,1
0,0.425170488,3,37,GO:0042742;GO:0009617,response to bacterium,1
0,0.426748731,3,43,GO:0010639,negative regulation of organelle organization,1
0,0.428487181,2,204,GO:0022402,cell cycle process,1
0,0.428940791,3,66,GO:0006954,inflammatory response,1
0,0.430156484,2,19,GO:0050777,negative regulation of immune response,1
0,0.430437596,4,15,GO:0006641;GO:0006639;GO:0006638,acylglycerol metabolic process,1
0,0.431936116,2,75,GO:0001775,cell activation,1
0,0.434286409,2,131,GO:0030029;GO:0030036,actin filament-based process,1
0,0.434823066,2,105,GO:0003006,developmental process involved in reproduction,1
0,0.436540417,4,26,GO:0009062;GO:0019395;GO:0072329;GO:0034440;GO:0030258,lipid modification,1
0,0.436999542,3,135,GO:0019725,cellular homeostasis,1
0,0.438787595,2,24,GO:0019932,second-messenger-mediated signaling,1
0,0.441683621,2,588,GO:0006464;GO:0036211;GO:0044267;GO:0043412,cellular protein metabolic process,1
0,0.447992523,2,26,GO:0006584;GO:0009712;GO:0018958,phenol-containing compound metabolic process,1
0,0.450485454,2,63,GO:0051259,protein complex oligomerization,1
0,0.454775629,2,76,GO:0034470,ncRNA processing,1
0,0.455406298,3,96,GO:0009790,embryo development,1
0,0.456977904,3,26,GO:0031667;GO:0009991,response to extracellular stimulus,1
0,0.459545129,3,19,GO:0002700,regulation of production of molecular mediator of immune response,1
0,0.464575999,4,34,GO:0060249,anatomical structure homeostasis,1
0,0.464626977,3,18,GO:0043687,post-translational protein modification,1
0,0.465554492,2,20,GO:0006839,mitochondrial transport,1
0,0.468165662,5,21,GO:0000079;GO:1904029,regulation of cyclin-dependent protein kinase activity,1
0,0.470077507,2,17,GO:0045834,positive regulation of lipid metabolic process,1
0,0.474519563,2,88,GO:0046394;GO:0016053,carboxylic acid biosynthetic process,1
0,0.475081011,4,20,GO:0051092,positive regulation of NF-kappaB transcription factor activity,1
0,0.477314735,2,19,GO:0007492,endoderm development,1
0,0.478917694,3,24,GO:0006935;GO:0042330,taxis,1
0,0.47960002,2,109,GO:0006897;GO:0098657,import into cell,1
0,0.481119755,4,55,GO:0030855,epithelial cell differentiation,1
0,0.482656983,4,18,GO:0023061,signal release,1
0,0.484468748,2,113,GO:0048878,chemical homeostasis,1
0,0.490830066,3,27,GO:0006275,regulation of DNA replication,1
0,0.492358214,3,61,GO:0033993,response to lipid,1
0,0.492435928,3,19,GO:0051054,positive regulation of DNA metabolic process,1
0,0.505213956,2,67,GO:0016042,lipid catabolic process,1
0,0.505939899,2,33,GO:0050808,synapse organization,1
0,0.50748262,4,24,GO:0000086;GO:0044839,cell cycle G2/M phase transition,1
0,0.50748262,2,24,GO:0071901;GO:0006469;GO:0033673;GO:0051348,negative regulation of protein kinase activity,1
0,0.507787725,4,49,GO:0001667,ameboidal-type cell migration,1
0,0.513499893,3,21,GO:0030097,hemopoiesis,1
0,0.515386136,3,295,GO:0006629,lipid metabolic process,1
0,0.517734649,5,19,GO:0045162;GO:0045161,neuronal ion channel clustering,1
0,0.519412881,4,23,GO:0009953,dorsal/ventral pattern formation,1
0,0.52022306,2,121,GO:0044419,interspecies interaction between organisms,1
0,0.523592803,4,19,GO:0006555;GO:0009086;GO:0000097;GO:0009067,aspartate family amino acid biosynthetic process,1
0,0.527170679,2,137,GO:0044283,small molecule biosynthetic process,1
0,0.527953971,5,25,GO:0072331,signal transduction by p53 class mediator,1
0,0.529558419,2,46,GO:0000956;GO:0006402;GO:0006401,RNA catabolic process,1
0,0.531224696,3,25,GO:0006662;GO:0018904,glycerol ether metabolic process,1
0,0.531311339,7,29,GO:0050770,regulation of axonogenesis,1
0,0.535157045,2,40,GO:0046395;GO:0016054,carboxylic acid catabolic process,1
0,0.53786313,2,132,GO:0034660,ncRNA metabolic process,1
0,0.537920305,4,127,GO:0051093,negative regulation of developmental process,1
0,0.53877201,2,492,GO:0007166,cell surface receptor signaling pathway,1
0,0.540540514,4,30,GO:0045665,negative regulation of neuron differentiation,1
0,0.542471343,3,72,GO:0010817,regulation of hormone levels,1
0,0.542471531,5,24,GO:0042058;GO:1901184,regulation of ERBB signaling pathway,1
0,0.551554539,2,29,GO:0007162,negative regulation of cell adhesion,1
0,0.553804932,2,60,GO:0051336,regulation of hydrolase activity,1
0,0.55505647,4,23,GO:0032436;GO:1901800;GO:2000060;GO:1903052;GO:1903364,positive regulation of ubiquitin-dependent protein catabolic process,1
0,0.555351682,4,25,GO:0051051,negative regulation of transport,1
0,0.561765991,3,28,GO:0051098,regulation of binding,1
0,0.565525871,2,41,GO:0010038,response to metal ion,1
0,0.565938242,3,57,GO:0006418;GO:0043039;GO:0006399;GO:0043038,tRNA metabolic process,1
0,0.56852264,5,29,GO:0045787,positive regulation of cell cycle,1
0,0.574556387,3,22,GO:0000096,sulfur amino acid metabolic process,1
0,0.574556387,4,22,GO:0009066,aspartate family amino acid metabolic process,1
0,0.577330742,3,26,GO:0009798,axis specification,1
0,0.58980558,2,244,GO:0048513,animal organ development,1
0,0.594674039,4,27,GO:0018279;GO:0006487;GO:0018196,protein N-linked glycosylation,1
0,0.600748802,1,79,GO:0007610,behavior,1
0,0.603102717,2,59,GO:0044282,small molecule catabolic process,1
0,0.604011081,2,24,GO:0048666,neuron development,1
0,0.605564994,2,54,GO:0006754;GO:0009206;GO:0046034;GO:0009145;GO:0009201;GO:0009205;GO:0009142;GO:0009144;GO:0009199;GO:0009141,nucleoside triphosphate metabolic process,1
0,0.61159445,2,99,GO:0007389,pattern specification process,1
0,0.61870463,3,32,GO:0051260,protein homooligomerization,1
0,0.619974808,2,28,GO:0032434;GO:2000058,regulation of ubiquitin-dependent protein catabolic process,1
0,0.620669209,3,55,GO:0010035,response to inorganic substance,1
0,0.622037381,2,35,GO:0042445,hormone metabolic process,1
0,0.622260078,2,85,GO:0045596,negative regulation of cell differentiation,1
0,0.625506957,4,34,GO:0016482,cytosolic transport,1
0,0.6441657,4,38,GO:0006099;GO:0006101;GO:0072350,citrate metabolic process,1
0,0.644624548,4,39,GO:0001933;GO:0042326;GO:0045936;GO:0043086;GO:0010563,negative regulation of phosphate metabolic process,1
0,0.645998571,6,46,GO:0010769,regulation of cell morphogenesis involved in differentiation,1
0,0.647067884,2,37,GO:0007596;GO:0007599;GO:0050817,blood coagulation,1
0,0.65044576,2,29,GO:1901136,carbohydrate derivative catabolic process,1
0,0.657163838,3,178,GO:0017144,drug metabolic process,1
0,0.659502785,5,246,GO:0031324;GO:0051172,negative regulation of cellular metabolic process,1
0,0.661744366,2,30,GO:0006665;GO:0006643,membrane lipid metabolic process,1
0,0.66570236,2,45,GO:1903311,regulation of mRNA metabolic process,1
0,0.667517716,3,42,GO:0007218,neuropeptide signaling pathway,1
0,0.668844962,4,43,GO:0044772;GO:0044770,mitotic cell cycle phase transition,1
0,0.673277571,2,836,GO:0048856,anatomical structure development,1
0,0.674080242,2,142,GO:1901565,organonitrogen compound catabolic process,1
0,0.679742582,3,91,GO:0030155,regulation of cell adhesion,1
0,0.682223062,1,245,GO:0022414,reproductive process,1
0,0.685841357,4,37,GO:0120031;GO:0030031,plasma membrane bounded cell projection assembly,1
0,0.686370438,3,94,GO:1903047,mitotic cell cycle process,1
0,0.692201528,3,57,GO:0006412,translation,1
0,0.692942348,2,33,GO:0046434,organophosphate catabolic process,1
0,0.707752597,2,40,GO:0035148,tube formation,1
0,0.707752597,4,40,GO:0050821;GO:0031647,regulation of protein stability,1
0,0.716103916,2,120,GO:0006457,protein folding,1
0,0.72083334,3,214,GO:0016477;GO:0048870;GO:0040011,locomotion,1
0,0.72320665,1,827,GO:0032501,multicellular organismal process,1
0,0.736844437,4,37,GO:0044057,regulation of system process,1
0,0.738683614,2,45,GO:0001701;GO:0043009,chordate embryonic development,1
0,0.743184239,2,56,GO:0006605,protein targeting,1
0,0.743919698,2,37,GO:0042391,regulation of membrane potential,1
0,0.746362138,2,103,GO:0030334;GO:2000145;GO:0040012;GO:0051270,regulation of locomotion,1
0,0.754776942,2,50,GO:0072593,reactive oxygen species metabolic process,1
0,0.758241106,2,43,GO:0007015,actin filament organization,1
0,0.76440969,2,69,GO:0016999,antibiotic metabolic process,1
0,0.76664636,4,56,GO:0051028;GO:0050658;GO:0050657;GO:0051236;GO:0015931,nucleobase-containing compound transport,1
0,0.773589232,3,89,GO:1901137,carbohydrate derivative biosynthetic process,1
0,0.776820214,2,161,GO:1901135,carbohydrate derivative metabolic process,1
0,0.779851033,2,79,GO:0008202,steroid metabolic process,1
0,0.780058662,4,71,GO:0072594;GO:0033365,protein localization to organelle,1
0,0.783091316,5,143,GO:0006511;GO:0019941;GO:0051603;GO:0043632,proteolysis involved in cellular protein catabolic process,1
0,0.784969144,2,209,GO:0003008;GO:0050877,system process,1
0,0.791130445,2,94,GO:0007186,G protein-coupled receptor signaling pathway,1
0,0.798522325,2,592,GO:0006351;GO:0097659;GO:0032774,RNA biosynthetic process,1
0,0.801946159,2,322,GO:0010629;GO:0010605;GO:0009892,negative regulation of metabolic process,1
0,0.808707602,3,169,GO:0007167;GO:0007169,enzyme linked receptor protein signaling pathway,1
0,0.81294193,2,177,GO:0007264,small GTPase mediated signal transduction,1
0,0.813342426,4,116,GO:0007411;GO:0097485,axon guidance,1
0,0.822896567,3,69,GO:0048729;GO:0002009,tissue morphogenesis,1
0,0.841943831,2,234,GO:0009057;GO:0044265,macromolecule catabolic process,1
0,0.84594974,2,404,GO:0035556,intracellular signal transduction,1
0,0.847632387,2,86,GO:0007163,establishment or maintenance of cell polarity,1
0,0.848918766,2,65,GO:0097435,supramolecular fiber organization,1
0,0.863972263,6,315,GO:0006396,RNA processing,1
0,0.86659984,4,71,GO:0007283;GO:0048232,male gamete generation,1
0,0.874512963,4,144,GO:0034613;GO:0070727,cellular macromolecule localization,1
0,0.876066238,4,107,GO:0034655;GO:0019439;GO:0044270;GO:0046700;GO:1901361,organic cyclic compound catabolic process,1
0,0.894432089,2,212,GO:0045892;GO:1903507;GO:2000113;GO:1902679;GO:0010558;GO:0031327;GO:0051253;GO:0009890;GO:0045934,negative regulation of biosynthetic process,1
0,0.90825318,2,281,GO:0006397;GO:0016071,mRNA metabolic process,1
0,0.955827146,2,419,GO:0044248;GO:1901575;GO:0009056,catabolic process,1
0,0.958842179,2,171,GO:0008380,RNA splicing,1
0,0.967773185,2,412,GO:0006928,movement of cell or subcellular component,1
0,1,3,24,GO:0000041,transition metal ion transport,1
0,1,3,6,GO:0000045;GO:1905037,autophagosome assembly,1
0,1,3,18,GO:0000082;GO:0044843,cell cycle G1/S phase transition,1
0,1,3,13,GO:0000084;GO:0051320,S phase,1
0,1,3,69,GO:0000122,negative regulation of transcription by RNA polymerase II,1
0,1,6,39,GO:0000165;GO:0023014,MAPK cascade,1
0,1,4,10,GO:0000236;GO:0098763,mitotic cell cycle phase,1
0,1,3,5,GO:0000245,spliceosomal complex assembly,1
0,1,2,5,GO:0000272,polysaccharide catabolic process,1
0,1,2,6,GO:0000278,mitotic cell cycle,1
0,1,6,5,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,1
0,1,2,17,GO:0000302,response to reactive oxygen species,1
0,1,3,5,GO:0000387,spliceosomal snRNP assembly,1
0,1,7,5,GO:0000724;GO:0000725,double-strand break repair via homologous recombination,1
0,1,2,24,GO:0000902;GO:0000904,cell morphogenesis,1
0,1,3,27,GO:0001501,skeletal system development,1
0,1,2,5,GO:0001502,cartilage condensation,1
0,1,2,32,GO:0001503,ossification,1
0,1,2,5,GO:0001522,pseudouridine synthesis,1
0,1,5,5,GO:0001523,retinoid metabolic process,1
0,1,3,9,GO:0001539,cilium or flagellum-dependent cell motility,1
0,1,2,10,GO:0001568,blood vessel development,1
0,1,5,18,GO:0001656,metanephros development,1
0,1,6,26,GO:0001657;GO:0072164;GO:0072163;GO:0072073,kidney epithelium development,1
0,1,4,5,GO:0001658,branching involved in ureteric bud morphogenesis,1
0,1,4,32,GO:0001666;GO:0036293;GO:0070482,response to decreased oxygen levels,1
0,1,2,35,GO:0001704,formation of primary germ layer,1
0,1,2,23,GO:0001707,mesoderm formation,1
0,1,4,7,GO:0001736;GO:0007164,establishment of planar polarity,1
0,1,3,8,GO:0001754;GO:0046530;GO:0046532,eye photoreceptor cell differentiation,1
0,1,2,13,GO:0001755,neural crest cell migration,1
0,1,4,18,GO:0001764,neuron migration,1
0,1,2,8,GO:0001778,plasma membrane repair,1
0,1,5,8,GO:0001841,neural tube formation,1
0,1,5,6,GO:0001889,liver development,1
0,1,2,23,GO:0001894,tissue homeostasis,1
0,1,4,12,GO:0001936;GO:0001938,regulation of endothelial cell proliferation,1
0,1,2,9,GO:0001944,vasculature development,1
0,1,5,15,GO:0001952;GO:0051893;GO:0090109;GO:1903391;GO:1901888;GO:0042060,regulation of cell-matrix adhesion,1
0,1,3,8,GO:0001959;GO:0060759,regulation of cytokine-mediated signaling pathway,1
0,1,2,5,GO:0001967,suckling behavior,1
0,1,3,12,GO:0002011,morphogenesis of an epithelial sheet,1
0,1,2,17,GO:0002053;GO:0010464,regulation of mesenchymal cell proliferation,1
0,1,4,7,GO:0002062,chondrocyte differentiation,1
0,1,4,6,GO:0002066,columnar/cuboidal epithelial cell development,1
0,1,3,7,GO:0002067,glandular epithelial cell differentiation,1
0,1,3,11,GO:0002274,myeloid leukocyte activation,1
0,1,3,5,GO:0002443,leukocyte mediated immunity,1
0,1,2,18,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,1
0,1,6,5,GO:0002551;GO:0097531,mast cell chemotaxis,1
0,1,5,12,GO:0002573,myeloid leukocyte differentiation,1
0,1,3,5,GO:0002576,platelet degranulation,1
0,1,4,12,GO:0002637;GO:0051023,regulation of immunoglobulin production,1
0,1,3,6,GO:0002862;GO:0002861,regulation of inflammatory response to antigenic stimulus,1
0,1,5,6,GO:0002920,regulation of humoral immune response,1
0,1,6,8,GO:0003156,regulation of animal organ formation,1
0,1,5,23,GO:0005977;GO:0006073;GO:0044042;GO:0044264;GO:0005976,polysaccharide metabolic process,1
0,1,6,5,GO:0005978;GO:0009250,glucan biosynthetic process,1
0,1,4,7,GO:0005979;GO:0010962;GO:0070873;GO:0032885;GO:0032881,regulation of glycogen biosynthetic process,1
0,1,3,11,GO:0006004,fucose metabolic process,1
0,1,2,29,GO:0006006,glucose metabolic process,1
0,1,3,8,GO:0006013,mannose metabolic process,1
0,1,3,6,GO:0006020,inositol metabolic process,1
0,1,4,6,GO:0006024;GO:0006023,glycosaminoglycan biosynthetic process,1
0,1,6,19,GO:0006094;GO:0019319;GO:0046364,monosaccharide biosynthetic process,1
0,1,6,22,GO:0006096;GO:0006757;GO:0009166;GO:0019359;GO:0042866;GO:0006165;GO:0046031;GO:1901292;GO:0019363;GO:0006090;GO:0009132;GO:0046939;GO:0009179;GO:0009135;GO:0009185,nucleotide catabolic process,1
0,1,3,11,GO:0006097;GO:0046487,glyoxylate metabolic process,1
0,1,2,7,GO:0006102,isocitrate metabolic process,1
0,1,6,7,GO:0006111;GO:0010677;GO:0045912,regulation of gluconeogenesis,1
0,1,5,10,GO:0006144,purine nucleobase metabolic process,1
0,1,5,6,GO:0006188;GO:0009168;GO:0046040;GO:0009127;GO:0009167;GO:0009126,purine ribonucleoside monophosphate biosynthetic process,1
0,1,2,9,GO:0006206;GO:0072529,pyrimidine nucleobase metabolic process,1
0,1,5,6,GO:0006208;GO:0046113,nucleobase catabolic process,1
0,1,3,49,GO:0006260,DNA replication,1
0,1,2,11,GO:0006261,DNA-dependent DNA replication,1
0,1,2,7,GO:0006266,DNA ligation,1
0,1,2,7,GO:0006283,transcription-coupled nucleotide-excision repair,1
0,1,3,5,GO:0006284,base-excision repair,1
0,1,5,13,GO:0006289,nucleotide-excision repair,1
0,1,5,10,GO:0006306;GO:0006305;GO:0044728;GO:0006304,DNA modification,1
0,1,4,15,GO:0006309;GO:0000737;GO:0006308,DNA catabolic process,1
0,1,2,122,GO:0006325,chromatin organization,1
0,1,2,8,GO:0006333,chromatin assembly or disassembly,1
0,1,3,24,GO:0006334;GO:0065004,nucleosome assembly,1
0,1,3,6,GO:0006337;GO:0032986,nucleosome disassembly,1
0,1,2,37,GO:0006338,chromatin remodeling,1
0,1,3,23,GO:0006342;GO:0045814;GO:0097549;GO:0034401,chromatin organization involved in regulation of transcription,1
0,1,3,13,GO:0006367,transcription initiation from RNA polymerase II promoter,1
0,1,2,9,GO:0006369,termination of RNA polymerase II transcription,1
0,1,2,6,GO:0006370;GO:0009452;GO:0036260,7-methylguanosine mRNA capping,1
0,1,3,9,GO:0006378;GO:0043631,RNA polyadenylation,1
0,1,2,11,GO:0006379;GO:0090501,mRNA cleavage,1
0,1,3,6,GO:0006403,RNA localization,1
0,1,2,16,GO:0006406;GO:0006405,RNA export from nucleus,1
0,1,8,5,GO:0006438,valyl-tRNA aminoacylation,1
0,1,4,6,GO:0006465,signal peptide processing,1
0,1,3,27,GO:0006470;GO:0016311,dephosphorylation,1
0,1,3,37,GO:0006475;GO:0006473;GO:0043543,protein acylation,1
0,1,3,13,GO:0006493,protein O-linked glycosylation,1
0,1,3,10,GO:0006497,protein lipidation,1
0,1,5,6,GO:0006505;GO:0009247,GPI anchor metabolic process,1
0,1,2,9,GO:0006509;GO:0042987;GO:0042982,amyloid precursor protein catabolic process,1
0,1,2,11,GO:0006513,protein monoubiquitination,1
0,1,3,6,GO:0006516,glycoprotein catabolic process,1
0,1,5,5,GO:0006544,glycine metabolic process,1
0,1,2,10,GO:0006559;GO:0006558;GO:0009074;GO:1902222;GO:1902221;GO:0006570,aromatic amino acid family catabolic process,1
0,1,7,5,GO:0006560,proline metabolic process,1
0,1,2,6,GO:0006572,tyrosine catabolic process,1
0,1,4,28,GO:0006606;GO:0017038;GO:0034504;GO:0051170,protein import,1
0,1,2,22,GO:0006612,protein targeting to membrane,1
0,1,4,6,GO:0006614;GO:0006613,cotranslational protein targeting to membrane,1
0,1,4,7,GO:0006620,posttranslational protein targeting to endoplasmic reticulum membrane,1
0,1,7,6,GO:0006622;GO:0061462,protein localization to lysosome,1
0,1,5,9,GO:0006623;GO:0072666;GO:0072665,protein localization to vacuole,1
0,1,6,7,GO:0006625;GO:0043574;GO:0072663;GO:0072662;GO:0007031,peroxisome organization,1
0,1,3,26,GO:0006633,fatty acid biosynthetic process,1
0,1,3,10,GO:0006637;GO:0035383,thioester metabolic process,1
0,1,2,7,GO:0006661,phosphatidylinositol biosynthetic process,1
0,1,3,14,GO:0006672,ceramide metabolic process,1
0,1,5,11,GO:0006691,leukotriene metabolic process,1
0,1,3,6,GO:0006693,prostaglandin metabolic process,1
0,1,3,25,GO:0006694,steroid biosynthetic process,1
0,1,2,8,GO:0006695;GO:0016126;GO:1902653,cholesterol biosynthetic process,1
0,1,2,5,GO:0006703,estrogen biosynthetic process,1
0,1,2,14,GO:0006720,isoprenoid metabolic process,1
0,1,3,7,GO:0006760,folic acid-containing compound metabolic process,1
0,1,3,27,GO:0006766,vitamin metabolic process,1
0,1,2,19,GO:0006767,water-soluble vitamin metabolic process,1
0,1,2,5,GO:0006775,fat-soluble vitamin metabolic process,1
0,1,3,17,GO:0006778;GO:0033013,tetrapyrrole metabolic process,1
0,1,4,15,GO:0006783;GO:0006779;GO:0042168;GO:0033014,heme metabolic process,1
0,1,2,20,GO:0006801,superoxide metabolic process,1
0,1,3,176,GO:0006811,ion transport,1
0,1,2,119,GO:0006812,cation transport,1
0,1,2,9,GO:0006813,potassium ion transport,1
0,1,4,28,GO:0006814,sodium ion transport,1
0,1,5,20,GO:0006816,calcium ion transport,1
0,1,2,6,GO:0006825,copper ion transport,1
0,1,2,6,GO:0006826,iron ion transport,1
0,1,5,10,GO:0006829,zinc ion transport,1
0,1,4,5,GO:0006833;GO:0042044,water transport,1
0,1,3,20,GO:0006865,amino acid transport,1
0,1,2,6,GO:0006878;GO:0055070,copper ion homeostasis,1
0,1,3,10,GO:0006879,cellular iron ion homeostasis,1
0,1,7,15,GO:0006885;GO:0055067;GO:0051453;GO:0030641;GO:0030004,monovalent inorganic cation homeostasis,1
0,1,2,5,GO:0006891,intra-Golgi vesicle-mediated transport,1
0,1,3,25,GO:0006893;GO:0098876;GO:0043001;GO:0061951;GO:0072659;GO:1990778,Golgi to plasma membrane transport,1
0,1,2,16,GO:0006895,Golgi to endosome transport,1
0,1,2,25,GO:0006898,receptor-mediated endocytosis,1
0,1,2,11,GO:0006901,vesicle coating,1
0,1,2,5,GO:0006903,vesicle targeting,1
0,1,2,12,GO:0006909,phagocytosis,1
0,1,5,48,GO:0006913;GO:0051169,nucleocytoplasmic transport,1
0,1,2,10,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,1
0,1,4,24,GO:0006936;GO:0003012,muscle system process,1
0,1,5,5,GO:0006939,smooth muscle contraction,1
0,1,5,12,GO:0006941,striated muscle contraction,1
0,1,3,13,GO:0006953;GO:0002526,acute inflammatory response,1
0,1,2,5,GO:0006970,response to osmotic stress,1
0,1,6,15,GO:0006977;GO:0072431;GO:1902400;GO:1902402;GO:0072422;GO:1902403;GO:0072401;GO:0072395;GO:0072413;GO:0000216;GO:0051437;GO:0006521;GO:0033238,obsolete M/G1 transition of mitotic cell cycle,1
0,1,5,7,GO:0006983,ER overload response,1
0,1,4,16,GO:0006984,ER-nucleus signaling pathway,1
0,1,3,22,GO:0006986;GO:0035966,response to topologically incorrect protein,1
0,1,2,19,GO:0007009,plasma membrane organization,1
0,1,3,5,GO:0007016,cytoskeletal anchoring at plasma membrane,1
0,1,4,5,GO:0007020,microtubule nucleation,1
0,1,7,10,GO:0007026;GO:0031111;GO:0031114,regulation of microtubule depolymerization,1
0,1,2,5,GO:0007029,endoplasmic reticulum organization,1
0,1,2,41,GO:0007030,Golgi organization,1
0,1,2,34,GO:0007034;GO:0007041,vacuolar transport,1
0,1,8,5,GO:0007035;GO:0051452;GO:0045851,intracellular pH reduction,1
0,1,2,24,GO:0007043;GO:0045216,cell-cell junction organization,1
0,1,2,30,GO:0007044,cell-substrate junction assembly,1
0,1,4,12,GO:0007051,spindle organization,1
0,1,2,6,GO:0007052,mitotic spindle organization,1
0,1,6,10,GO:0007076,mitotic chromosome condensation,1
0,1,5,7,GO:0007094;GO:0045841;GO:0071173;GO:0071174;GO:1902100;GO:2000816;GO:0033048;GO:1905819;GO:0033046;GO:0045839;GO:0051985;GO:2001251;GO:0051784;GO:0031577,negative regulation of mitotic nuclear division,1
0,1,4,9,GO:0007097;GO:0051647,nucleus localization,1
0,1,4,6,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,1
0,1,3,16,GO:0007160,cell-matrix adhesion,1
0,1,5,26,GO:0007173;GO:0038127,ERBB signaling pathway,1
0,1,2,25,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,1,2,17,GO:0007179,transforming growth factor beta receptor signaling pathway,1
0,1,2,14,GO:0007185,transmembrane receptor protein tyrosine phosphatase signaling pathway,1
0,1,7,5,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,1
0,1,2,12,GO:0007205,protein kinase C-activating G protein-coupled receptor signaling pathway,1
0,1,3,12,GO:0007213;GO:0095500;GO:1903831,acetylcholine receptor signaling pathway,1
0,1,5,11,GO:0007220,Notch receptor processing,1
0,1,3,37,GO:0007229,integrin-mediated signaling pathway,1
0,1,3,14,GO:0007254,JNK cascade,1
0,1,6,34,GO:0007265,Ras protein signal transduction,1
0,1,2,14,GO:0007266,Rho protein signal transduction,1
0,1,3,5,GO:0007279,pole cell formation,1
0,1,3,11,GO:0007298;GO:0007297,ovarian follicle cell migration,1
0,1,2,11,GO:0007349,cellularization,1
0,1,3,5,GO:0007379,segment specification,1
0,1,5,10,GO:0007391;GO:0048563,dorsal closure,1
0,1,2,65,GO:0007399,nervous system development,1
0,1,2,32,GO:0007409,axonogenesis,1
0,1,3,6,GO:0007416,synapse assembly,1
0,1,3,35,GO:0007420,brain development,1
0,1,2,9,GO:0007422,peripheral nervous system development,1
0,1,2,13,GO:0007498,mesoderm development,1
0,1,3,32,GO:0007507,heart development,1
0,1,5,5,GO:0007512,adult heart development,1
0,1,4,15,GO:0007517;GO:0061061,muscle organ development,1
0,1,6,7,GO:0007519,skeletal muscle tissue development,1
0,1,3,17,GO:0007528,neuromuscular junction development,1
0,1,2,8,GO:0007548,sex differentiation,1
0,1,2,6,GO:0007566,embryo implantation,1
0,1,2,23,GO:0007568,aging,1
0,1,2,12,GO:0007569,cell aging,1
0,1,2,8,GO:0007584,response to nutrient,1
0,1,2,7,GO:0007585,respiratory gaseous exchange,1
0,1,2,10,GO:0007586,digestion,1
0,1,4,119,GO:0007600,sensory perception,1
0,1,6,57,GO:0007601;GO:0050953,visual perception,1
0,1,2,5,GO:0007602,phototransduction,1
0,1,6,41,GO:0007605;GO:0050954,sensory perception of sound,1
0,1,2,11,GO:0007606,sensory perception of chemical stimulus,1
0,1,2,8,GO:0007608,sensory perception of smell,1
0,1,4,25,GO:0007611;GO:0050890,cognition,1
0,1,2,9,GO:0007616;GO:0007613,memory,1
0,1,3,5,GO:0007617,mating behavior,1
0,1,2,11,GO:0007631,feeding behavior,1
0,1,2,14,GO:0007635,chemosensory behavior,1
0,1,5,7,GO:0008045,motor neuron axon guidance,1
0,1,2,9,GO:0008154;GO:0030041,actin polymerization or depolymerization,1
0,1,2,52,GO:0008203;GO:0016125;GO:1902652,sterol metabolic process,1
0,1,5,9,GO:0008210,estrogen metabolic process,1
0,1,2,14,GO:0008217,regulation of blood pressure,1
0,1,5,11,GO:0008277,regulation of G protein-coupled receptor signaling pathway,1
0,1,2,30,GO:0008286,insulin receptor signaling pathway,1
0,1,2,6,GO:0008293,torso signaling pathway,1
0,1,3,8,GO:0008299,isoprenoid biosynthetic process,1
0,1,2,7,GO:0008306;GO:0007612,learning,1
0,1,2,16,GO:0008333,endosome to lysosome transport,1
0,1,3,10,GO:0008344;GO:0030534,adult behavior,1
0,1,4,6,GO:0008347,glial cell migration,1
0,1,2,9,GO:0008354,germ cell migration,1
0,1,3,11,GO:0008356,asymmetric cell division,1
0,1,4,13,GO:0008406,gonad development,1
0,1,2,7,GO:0008407,chaeta morphogenesis,1
0,1,5,28,GO:0008543,fibroblast growth factor receptor signaling pathway,1
0,1,2,8,GO:0008589,regulation of smoothened signaling pathway,1
0,1,5,6,GO:0008615;GO:0008614;GO:0042819;GO:0042816,pyridoxine biosynthetic process,1
0,1,2,6,GO:0008637,apoptotic mitochondrial changes,1
0,1,3,20,GO:0009063;GO:1901606,cellular amino acid catabolic process,1
0,1,3,13,GO:0009072,aromatic amino acid family metabolic process,1
0,1,5,10,GO:0009084,glutamine family amino acid biosynthetic process,1
0,1,3,17,GO:0009100,glycoprotein metabolic process,1
0,1,5,5,GO:0009109,coenzyme catabolic process,1
0,1,4,17,GO:0009112,nucleobase metabolic process,1
0,1,2,5,GO:0009113,purine nucleobase biosynthetic process,1
0,1,5,24,GO:0009116;GO:1901657,nucleoside metabolic process,1
0,1,6,9,GO:0009163;GO:1901659,nucleoside biosynthetic process,1
0,1,3,11,GO:0009164;GO:0034656;GO:1901658,nucleoside catabolic process,1
0,1,2,8,GO:0009220;GO:0009218,pyrimidine ribonucleotide metabolic process,1
0,1,4,5,GO:0009303;GO:0098781,rRNA transcription,1
0,1,4,14,GO:0009306;GO:0002790,peptide secretion,1
0,1,3,11,GO:0009405,pathogenesis,1
0,1,2,26,GO:0009408;GO:0009266,response to temperature stimulus,1
0,1,2,5,GO:0009409,response to cold,1
0,1,2,12,GO:0009566;GO:0007338,fertilization,1
0,1,4,7,GO:0009583,detection of light stimulus,1
0,1,3,42,GO:0009611,response to wounding,1
0,1,5,20,GO:0009749;GO:0009746;GO:0034284;GO:0009743,response to carbohydrate,1
0,1,2,7,GO:0009751,response to salicylic acid,1
0,1,3,16,GO:0009886,post-embryonic animal morphogenesis,1
0,1,3,8,GO:0009914;GO:0046879,hormone transport,1
0,1,4,7,GO:0009950,dorsal/ventral axis specification,1
0,1,2,7,GO:0009954,proximal/distal pattern formation,1
0,1,3,6,GO:0010039,response to iron ion,1
0,1,3,12,GO:0010453,regulation of cell fate commitment,1
0,1,2,7,GO:0010454,negative regulation of cell fate commitment,1
0,1,4,13,GO:0010506,regulation of autophagy,1
0,1,2,8,GO:0010508,positive regulation of autophagy,1
0,1,4,13,GO:0010517;GO:0060191,regulation of lipase activity,1
0,1,3,9,GO:0010518;GO:0060193,positive regulation of phospholipase activity,1
0,1,2,20,GO:0010565,regulation of cellular ketone metabolic process,1
0,1,2,7,GO:0010623,programmed cell death involved in cell development,1
0,1,3,34,GO:0010632,regulation of epithelial cell migration,1
0,1,3,6,GO:0010633,negative regulation of epithelial cell migration,1
0,1,2,18,GO:0010634,positive regulation of epithelial cell migration,1
0,1,3,10,GO:0010675;GO:0010906;GO:0043255,regulation of glucose metabolic process,1
0,1,2,6,GO:0010761;GO:0048008,fibroblast migration,1
0,1,2,19,GO:0010810,regulation of cell-substrate adhesion,1
0,1,4,5,GO:0010812,negative regulation of cell-substrate adhesion,1
0,1,2,15,GO:0010827,regulation of glucose transmembrane transport,1
0,1,8,5,GO:0010863;GO:1900274,positive regulation of phospholipase C activity,1
0,1,2,7,GO:0010866,regulation of triglyceride biosynthetic process,1
0,1,4,5,GO:0010867;GO:0046889,positive regulation of triglyceride biosynthetic process,1
0,1,4,5,GO:0010912;GO:0010911,regulation of isomerase activity,1
0,1,3,18,GO:0010927,cellular component assembly involved in morphogenesis,1
0,1,2,20,GO:0014706;GO:0060537,muscle tissue development,1
0,1,2,8,GO:0015669,gas transport,1
0,1,2,66,GO:0015672,monovalent inorganic cation transport,1
0,1,4,6,GO:0015701,bicarbonate transport,1
0,1,3,51,GO:0015711;GO:0006820,anion transport,1
0,1,3,10,GO:0015718,monocarboxylic acid transport,1
0,1,4,13,GO:0015850,organic hydroxy compound transport,1
0,1,3,21,GO:0015893,drug transport,1
0,1,2,5,GO:0015908,fatty acid transport,1
0,1,2,7,GO:0015914;GO:0015748,phospholipid transport,1
0,1,2,6,GO:0015936,coenzyme A metabolic process,1
0,1,3,12,GO:0015986;GO:0015985,ATP synthesis coupled proton transport,1
0,1,3,30,GO:0016051,carbohydrate biosynthetic process,1
0,1,2,22,GO:0016052,carbohydrate catabolic process,1
0,1,7,5,GO:0016073,snRNA metabolic process,1
0,1,3,7,GO:0016101;GO:0006721,terpenoid metabolic process,1
0,1,5,19,GO:0016199;GO:0016198,axon midline choice point recognition,1
0,1,3,15,GO:0016202;GO:0048634;GO:1901861,regulation of muscle organ development,1
0,1,4,6,GO:0016226;GO:0031163,iron-sulfur cluster assembly,1
0,1,2,12,GO:0016331,morphogenesis of embryonic epithelium,1
0,1,2,47,GO:0016458,gene silencing,1
0,1,3,32,GO:0016485,protein processing,1
0,1,2,11,GO:0016486,peptide hormone processing,1
0,1,3,51,GO:0016570;GO:0016569,covalent chromatin modification,1
0,1,3,25,GO:0016573;GO:0018393;GO:0018394,internal peptidyl-lysine acetylation,1
0,1,5,12,GO:0016574,histone ubiquitination,1
0,1,2,7,GO:0016601,Rac protein signal transduction,1
0,1,2,9,GO:0016925,protein sumoylation,1
0,1,2,6,GO:0017000,antibiotic biosynthetic process,1
0,1,3,9,GO:0017145,stem cell division,1
0,1,3,26,GO:0017148;GO:0034249,negative regulation of translation,1
0,1,2,11,GO:0018105;GO:0018209,peptidyl-serine modification,1
0,1,3,5,GO:0018126,protein hydroxylation,1
0,1,2,56,GO:0018205,peptidyl-lysine modification,1
0,1,2,5,GO:0018210,peptidyl-threonine modification,1
0,1,2,16,GO:0018298,protein-chromophore linkage,1
0,1,2,7,GO:0019098,reproductive behavior,1
0,1,2,12,GO:0019217,regulation of fatty acid metabolic process,1
0,1,6,9,GO:0019229;GO:0097746;GO:0035296,regulation of tube diameter,1
0,1,2,10,GO:0019233,sensory perception of pain,1
0,1,4,7,GO:0019430;GO:0098869;GO:1990748;GO:0098754,removal of superoxide radicals,1
0,1,3,7,GO:0019432;GO:0046463;GO:0046460,acylglycerol biosynthetic process,1
0,1,7,7,GO:0019509;GO:0071267;GO:0043102;GO:0071265,L-methionine salvage from methylthioadenosine,1
0,1,2,11,GO:0019722,calcium-mediated signaling,1
0,1,3,10,GO:0019730,antimicrobial humoral response,1
0,1,2,6,GO:0019748,secondary metabolic process,1
0,1,2,17,GO:0019827;GO:0098727,stem cell population maintenance,1
0,1,2,9,GO:0019835,cytolysis,1
0,1,2,5,GO:0019852,L-ascorbic acid metabolic process,1
0,1,2,8,GO:0019884;GO:0002478,antigen processing and presentation of exogenous antigen,1
0,1,2,6,GO:0021510,spinal cord development,1
0,1,2,6,GO:0021515,cell differentiation in spinal cord,1
0,1,2,6,GO:0021537,telencephalon development,1
0,1,3,5,GO:0021545;GO:0021675,cranial nerve development,1
0,1,2,6,GO:0021549,cerebellum development,1
0,1,2,5,GO:0021587,cerebellum morphogenesis,1
0,1,2,22,GO:0021700;GO:0071695,developmental maturation,1
0,1,4,9,GO:0021782,glial cell development,1
0,1,6,11,GO:0021884;GO:0021954,central nervous system neuron development,1
0,1,2,7,GO:0021891,olfactory bulb interneuron development,1
0,1,3,7,GO:0021952;GO:0021955,central nervous system neuron axonogenesis,1
0,1,2,8,GO:0021987,cerebral cortex development,1
0,1,4,9,GO:0022008,neurogenesis,1
0,1,4,5,GO:0022029;GO:0021885,forebrain cell migration,1
0,1,2,30,GO:0022403;GO:0044848,biological phase,1
0,1,3,29,GO:0022411,cellular component disassembly,1
0,1,4,24,GO:0022904,respiratory electron transport chain,1
0,1,2,74,GO:0030001,metal ion transport,1
0,1,3,24,GO:0030010,establishment of cell polarity,1
0,1,2,21,GO:0030011,maintenance of cell polarity,1
0,1,2,6,GO:0030042;GO:0051261,protein depolymerization,1
0,1,2,19,GO:0030048,actin filament-based movement,1
0,1,2,8,GO:0030049;GO:0033275;GO:0070252,actin-mediated cell contraction,1
0,1,4,5,GO:0030072,peptide hormone secretion,1
0,1,2,53,GO:0030111,regulation of Wnt signaling pathway,1
0,1,3,5,GO:0030148,sphingolipid biosynthetic process,1
0,1,2,24,GO:0030168,platelet activation,1
0,1,2,29,GO:0030177,positive regulation of Wnt signaling pathway,1
0,1,2,22,GO:0030178;GO:0090090,negative regulation of Wnt signaling pathway,1
0,1,3,9,GO:0030199,collagen fibril organization,1
0,1,2,17,GO:0030203;GO:0006022,aminoglycan metabolic process,1
0,1,3,14,GO:0030241;GO:0071688;GO:0031034;GO:0031033,myosin filament organization,1
0,1,2,6,GO:0030279,negative regulation of ossification,1
0,1,2,6,GO:0030282,bone mineralization,1
0,1,2,8,GO:0030307,positive regulation of cell growth,1
0,1,2,7,GO:0030316,osteoclast differentiation,1
0,1,2,6,GO:0030323,respiratory tube development,1
0,1,3,11,GO:0030324,lung development,1
0,1,6,18,GO:0030330;GO:0042770,signal transduction in response to DNA damage,1
0,1,3,52,GO:0030335;GO:2000147;GO:0040017;GO:0051272,positive regulation of cellular component movement,1
0,1,3,12,GO:0030509,BMP signaling pathway,1
0,1,3,18,GO:0030510,regulation of BMP signaling pathway,1
0,1,4,11,GO:0030513;GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1
0,1,4,10,GO:0030514,negative regulation of BMP signaling pathway,1
0,1,3,5,GO:0030574,collagen catabolic process,1
0,1,5,14,GO:0030595;GO:0060326;GO:0097529,cell chemotaxis,1
0,1,2,7,GO:0030718,germ-line stem cell population maintenance,1
0,1,3,7,GO:0030838,positive regulation of actin filament polymerization,1
0,1,2,11,GO:0030866;GO:0030865,cortical actin cytoskeleton organization,1
0,1,2,5,GO:0030900,forebrain development,1
0,1,2,8,GO:0030901,midbrain development,1
0,1,4,5,GO:0030916,otic vesicle formation,1
0,1,3,10,GO:0030949;GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,1
0,1,5,8,GO:0030970;GO:0032527;GO:1903513,protein exit from endoplasmic reticulum,1
0,1,3,12,GO:0031018,endocrine pancreas development,1
0,1,2,9,GO:0031023,microtubule organizing center organization,1
0,1,3,17,GO:0031032,actomyosin structure organization,1
0,1,5,26,GO:0031047,gene silencing by RNA,1
0,1,3,10,GO:0031054,pre-miRNA processing,1
0,1,2,7,GO:0031099,regeneration,1
0,1,2,13,GO:0031110,regulation of microtubule polymerization or depolymerization,1
0,1,3,7,GO:0031122,cytoplasmic microtubule organization,1
0,1,2,17,GO:0031124;GO:0031123,RNA 3'-end processing,1
0,1,3,8,GO:0031128;GO:1905332;GO:0090190;GO:0061213;GO:0090189;GO:0061217,regulation of branching involved in ureteric bud morphogenesis,1
0,1,4,15,GO:0031145,anaphase-promoting complex-dependent catabolic process,1
0,1,4,7,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1
0,1,5,10,GO:0031290,retinal ganglion cell axon guidance,1
0,1,2,6,GO:0031293,membrane protein intracellular domain proteolysis,1
0,1,6,6,GO:0031295;GO:0031294,lymphocyte costimulation,1
0,1,2,10,GO:0031330;GO:0009895,negative regulation of catabolic process,1
0,1,2,8,GO:0031365,N-terminal protein amino acid modification,1
0,1,2,23,GO:0031398;GO:1903322,positive regulation of protein modification by small protein conjugation or removal,1
0,1,4,10,GO:0031408;GO:0031407,oxylipin metabolic process,1
0,1,4,19,GO:0031532,actin cytoskeleton reorganization,1
0,1,4,22,GO:0031581,hemidesmosome assembly,1
0,1,2,37,GO:0031589,cell-substrate adhesion,1
0,1,2,7,GO:0031641,regulation of myelination,1
0,1,2,17,GO:0031644,regulation of neurological system process,1
0,1,2,6,GO:0031645,negative regulation of neurological system process,1
0,1,2,9,GO:0031929,TOR signaling,1
0,1,5,6,GO:0032007,negative regulation of TOR signaling,1
0,1,2,6,GO:0032092,positive regulation of protein binding,1
0,1,2,6,GO:0032148,activation of protein kinase B activity,1
0,1,3,5,GO:0032231,regulation of actin filament bundle assembly,1
0,1,2,14,GO:0032273;GO:1902905;GO:0031334,positive regulation of supramolecular fiber organization,1
0,1,2,13,GO:0032355,response to estradiol,1
0,1,3,12,GO:0032364;GO:0033483,gas homeostasis,1
0,1,2,14,GO:0032386,regulation of intracellular transport,1
0,1,6,5,GO:0032435;GO:1901799;GO:2000059;GO:1903051;GO:1903363,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1
0,1,4,9,GO:0032438;GO:0048753,melanosome organization,1
0,1,4,7,GO:0032508;GO:0032392,DNA geometric change,1
0,1,3,8,GO:0032608,interferon-beta production,1
0,1,2,5,GO:0032653,regulation of interleukin-10 production,1
0,1,3,8,GO:0032735;GO:0002833,positive regulation of interleukin-12 production,1
0,1,3,11,GO:0032801,receptor catabolic process,1
0,1,2,12,GO:0032963,collagen metabolic process,1
0,1,2,14,GO:0032984,protein-containing complex disassembly,1
0,1,3,6,GO:0033157;GO:1903827,regulation of intracellular protein transport,1
0,1,-1,7,GO:0033261,obsolete regulation of S phase,1
0,1,2,10,GO:0033334,fin morphogenesis,1
0,1,3,7,GO:0033344;GO:0030301;GO:0015918,cholesterol transport,1
0,1,6,5,GO:0033523,histone H2B ubiquitination,1
0,1,4,9,GO:0033559;GO:0006692,unsaturated fatty acid metabolic process,1
0,1,3,12,GO:0033619,membrane protein proteolysis,1
0,1,3,7,GO:0033692;GO:0000271;GO:0034637,cellular carbohydrate biosynthetic process,1
0,1,6,15,GO:0033875;GO:0034032;GO:0033865,ribonucleoside bisphosphate metabolic process,1
0,1,2,46,GO:0034220,ion transmembrane transport,1
0,1,5,7,GO:0034311,diol metabolic process,1
0,1,2,57,GO:0034329;GO:0034330,cell junction organization,1
0,1,2,12,GO:0034332,adherens junction organization,1
0,1,-1,8,GO:0034339,obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor,1
0,1,2,6,GO:0034394,protein localization to cell surface,1
0,1,2,25,GO:0034404,nucleobase-containing small molecule biosynthetic process,1
0,1,3,7,GO:0034446,substrate adhesion-dependent cell spreading,1
0,1,4,11,GO:0034453,microtubule anchoring,1
0,1,2,15,GO:0034599,cellular response to oxidative stress,1
0,1,2,7,GO:0034612,response to tumor necrosis factor,1
0,1,3,5,GO:0034614,cellular response to reactive oxygen species,1
0,1,4,34,GO:0034728;GO:0071824,nucleosome organization,1
0,1,2,25,GO:0034762,regulation of transmembrane transport,1
0,1,2,6,GO:0034763;GO:0051771,negative regulation of transmembrane transport,1
0,1,5,15,GO:0034968;GO:0016571;GO:0018022;GO:0006479;GO:0008213,protein alkylation,1
0,1,2,5,GO:0035019,somatic stem cell population maintenance,1
0,1,4,8,GO:0035051,cardiocyte differentiation,1
0,1,2,7,GO:0035112,genitalia morphogenesis,1
0,1,-1,8,GO:0035121,obsolete tail morphogenesis,1
0,1,4,14,GO:0035162,embryonic hemopoiesis,1
0,1,2,13,GO:0035176;GO:0051703,intraspecies interaction between organisms,1
0,1,2,6,GO:0035194;GO:0016441,posttranscriptional gene silencing,1
0,1,6,7,GO:0035235;GO:0007215,glutamate receptor signaling pathway,1
0,1,2,6,GO:0035265,organ growth,1
0,1,5,13,GO:0035278;GO:0040033;GO:0045974,miRNA mediated inhibition of translation,1
0,1,8,8,GO:0035279;GO:0098795,mRNA cleavage involved in gene silencing,1
0,1,7,9,GO:0035303,regulation of dephosphorylation,1
0,1,6,6,GO:0035338;GO:0035336;GO:0046949;GO:0035337;GO:0071616;GO:0034030;GO:0034033;GO:0035384;GO:0033866,ribonucleoside bisphosphate biosynthetic process,1
0,1,3,5,GO:0035459,vesicle cargo loading,1
0,1,2,6,GO:0035564,regulation of kidney size,1
0,1,2,9,GO:0035567,non-canonical Wnt signaling pathway,1
0,1,2,8,GO:0035640,exploration behavior,1
0,1,5,6,GO:0035641;GO:0045794;GO:0006884;GO:2000969;GO:1900451;GO:2000311;GO:1900449;GO:0099601;GO:2000463;GO:0031646;GO:0051835;GO:0051968;GO:0097107;GO:0097106;GO:0098698;GO:0099084;GO:2000822;GO:1903365;GO:0021773;GO:0021879,positive regulation of neurological system process,1
0,1,2,6,GO:0035690,cellular response to drug,1
0,1,3,8,GO:0035821,modification of morphology or physiology of other organism,1
0,1,2,5,GO:0040001,establishment of mitotic spindle localization,1
0,1,2,5,GO:0040019,positive regulation of embryonic development,1
0,1,2,7,GO:0040024,dauer larval development,1
0,1,2,7,GO:0042048,olfactory behavior,1
0,1,6,5,GO:0042051,compound eye photoreceptor development,1
0,1,3,11,GO:0042059;GO:1901185,negative regulation of epidermal growth factor receptor signaling pathway,1
0,1,2,7,GO:0042157,lipoprotein metabolic process,1
0,1,2,7,GO:0042177,negative regulation of protein catabolic process,1
0,1,2,11,GO:0042364;GO:0009110,water-soluble vitamin biosynthetic process,1
0,1,2,14,GO:0042446,hormone biosynthetic process,1
0,1,4,7,GO:0042462;GO:0042461,eye photoreceptor cell development,1
0,1,2,8,GO:0042472,inner ear morphogenesis,1
0,1,4,6,GO:0042474;GO:0042473,middle ear morphogenesis,1
0,1,2,14,GO:0042475,odontogenesis of dentin-containing tooth,1
0,1,2,20,GO:0042476,odontogenesis,1
0,1,4,12,GO:0042542,response to hydrogen peroxide,1
0,1,2,11,GO:0042552;GO:0008366;GO:0007272,axon ensheathment,1
0,1,4,5,GO:0042554,superoxide anion generation,1
0,1,2,12,GO:0042558,pteridine-containing compound metabolic process,1
0,1,5,5,GO:0042559,pteridine-containing compound biosynthetic process,1
0,1,4,14,GO:0042593;GO:0033500,glucose homeostasis,1
0,1,6,6,GO:0042659,regulation of cell fate specification,1
0,1,4,15,GO:0042692,muscle cell differentiation,1
0,1,5,12,GO:0042730;GO:0030195;GO:0030193;GO:0050819;GO:0061045;GO:1900047;GO:0050818;GO:1900046;GO:1903035,regulation of coagulation,1
0,1,4,6,GO:0042733,embryonic digit morphogenesis,1
0,1,2,40,GO:0042737,drug catabolic process,1
0,1,3,33,GO:0042744;GO:0017001;GO:0042743;GO:0051187,cofactor catabolic process,1
0,1,2,13,GO:0042752,regulation of circadian rhythm,1
0,1,2,7,GO:0042773,ATP synthesis coupled electron transport,1
0,1,4,8,GO:0043011;GO:0001773;GO:0097028;GO:0019886;GO:0002495;GO:0002504;GO:0070498;GO:0045084;GO:0031666,myeloid dendritic cell differentiation,1
0,1,8,8,GO:0043046;GO:0034587,piRNA metabolic process,1
0,1,2,38,GO:0043062;GO:0030198,extracellular structure organization,1
0,1,3,13,GO:0043094,cellular metabolic compound salvage,1
0,1,3,5,GO:0043101,purine-containing compound salvage,1
0,1,2,15,GO:0043113;GO:0051668,localization within membrane,1
0,1,2,8,GO:0043152;GO:0019731,antibacterial humoral response,1
0,1,2,5,GO:0043277,apoptotic cell clearance,1
0,1,3,6,GO:0043388,positive regulation of DNA binding,1
0,1,2,15,GO:0043393,regulation of protein binding,1
0,1,4,10,GO:0043407,negative regulation of MAP kinase activity,1
0,1,5,16,GO:0043409,negative regulation of MAPK cascade,1
0,1,3,27,GO:0043414;GO:0032259,macromolecule methylation,1
0,1,2,6,GO:0043462,regulation of ATPase activity,1
0,1,3,17,GO:0043467;GO:0006109,regulation of carbohydrate metabolic process,1
0,1,1,6,GO:0043473,pigmentation,1
0,1,2,8,GO:0043496,regulation of protein homodimerization activity,1
0,1,7,6,GO:0043508,negative regulation of JUN kinase activity,1
0,1,2,5,GO:0043525;GO:1901216,positive regulation of neuron apoptotic process,1
0,1,-1,5,GO:0043526,obsolete neuroprotection,1
0,1,4,5,GO:0043552;GO:0043551;GO:0090218;GO:1903727;GO:0043550;GO:1903725,positive regulation of lipid kinase activity,1
0,1,3,8,GO:0043624,cellular protein complex disassembly,1
0,1,2,11,GO:0043627,response to estrogen,1
0,1,7,6,GO:0043666;GO:0010921;GO:0035304;GO:0035507,regulation of protein dephosphorylation,1
0,1,3,18,GO:0043902,positive regulation of multi-organism process,1
0,1,2,12,GO:0043954,cellular component maintenance,1
0,1,2,9,GO:0043966,histone H3 acetylation,1
0,1,6,10,GO:0043967,histone H4 acetylation,1
0,1,2,5,GO:0043968,histone H2A acetylation,1
0,1,5,5,GO:0044179;GO:0051715;GO:0031640;GO:0001906;GO:0044364,hemolysis in other organism,1
0,1,2,11,GO:0044764,multi-organism cellular process,1
0,1,2,19,GO:0045022;GO:0098927,early endosome to late endosome transport,1
0,1,6,13,GO:0045047;GO:0072599;GO:0070972,protein localization to endoplasmic reticulum,1
0,1,2,12,GO:0045055,regulated exocytosis,1
0,1,2,27,GO:0045104;GO:0045103,intermediate filament cytoskeleton organization,1
0,1,7,6,GO:0045123;GO:0030593;GO:0071621;GO:1990266;GO:0097530,neutrophil migration,1
0,1,2,5,GO:0045132,meiotic chromosome segregation,1
0,1,3,24,GO:0045165,cell fate commitment,1
0,1,2,5,GO:0045168,cell-cell signaling involved in cell fate commitment,1
0,1,2,17,GO:0045197;GO:0035088;GO:0061245,establishment or maintenance of bipolar cell polarity,1
0,1,5,7,GO:0045198;GO:0030859;GO:0035089;GO:0061162;GO:0061339,polarized epithelial cell differentiation,1
0,1,2,7,GO:0045199;GO:0035090,maintenance of apical/basal cell polarity,1
0,1,4,10,GO:0045444,fat cell differentiation,1
0,1,2,10,GO:0045446,endothelial cell differentiation,1
0,1,2,11,GO:0045453,bone resorption,1
0,1,2,12,GO:0045478;GO:0042062;GO:0048790;GO:0099558;GO:1990709;GO:0007274;GO:0030721,fusome organization,1
0,1,2,15,GO:0045494,photoreceptor cell maintenance,1
0,1,5,8,GO:0045598,regulation of fat cell differentiation,1
0,1,2,5,GO:0045599,negative regulation of fat cell differentiation,1
0,1,2,11,GO:0045686;GO:0048710,negative regulation of glial cell differentiation,1
0,1,2,12,GO:0045740,positive regulation of DNA replication,1
0,1,2,10,GO:0045746,negative regulation of Notch signaling pathway,1
0,1,-1,8,GO:0045749,obsolete negative regulation of S phase of mitotic cell cycle,1
0,1,3,19,GO:0045766;GO:1904018,positive regulation of angiogenesis,1
0,1,4,5,GO:0045777,positive regulation of blood pressure,1
0,1,5,5,GO:0045806;GO:0070086,ubiquitin-dependent endocytosis,1
0,1,3,10,GO:0045807,positive regulation of endocytosis,1
0,1,4,10,GO:0045821;GO:0006110;GO:0030813;GO:0045913;GO:0051197;GO:2001171;GO:0030811;GO:0043470;GO:0051196;GO:2001169;GO:0006140;GO:0051193;GO:1900371;GO:1903578;GO:0030808;GO:1900542;GO:0045981;GO:0062013;GO:0051194;GO:1900373;GO:1903580;GO:0030810;GO:1900544,positive regulation of small molecule metabolic process,1
0,1,3,8,GO:0045861,negative regulation of proteolysis,1
0,1,2,5,GO:0045879,negative regulation of smoothened signaling pathway,1
0,1,2,12,GO:0045947,negative regulation of translational initiation,1
0,1,5,25,GO:0045995,regulation of embryonic development,1
0,1,2,6,GO:0046058,cAMP metabolic process,1
0,1,5,11,GO:0046112;GO:0009156;GO:0009124;GO:0009123;GO:0009161,nucleoside monophosphate metabolic process,1
0,1,2,10,GO:0046128;GO:0009119;GO:0042278,ribonucleoside metabolic process,1
0,1,3,7,GO:0046129;GO:0042451;GO:0042455,ribonucleoside biosynthetic process,1
0,1,4,6,GO:0046135;GO:0006213,pyrimidine nucleoside metabolic process,1
0,1,2,5,GO:0046146,tetrahydrobiopterin metabolic process,1
0,1,2,21,GO:0046148;GO:0042440,pigment metabolic process,1
0,1,2,14,GO:0046165,alcohol biosynthetic process,1
0,1,2,5,GO:0046173,polyol biosynthetic process,1
0,1,4,8,GO:0046320,regulation of fatty acid oxidation,1
0,1,7,10,GO:0046329;GO:0032873;GO:0070303,negative regulation of stress-activated MAPK cascade,1
0,1,6,6,GO:0046425;GO:1904892,regulation of receptor signaling pathway via JAK-STAT,1
0,1,3,8,GO:0046456,icosanoid biosynthetic process,1
0,1,2,9,GO:0046467,membrane lipid biosynthetic process,1
0,1,2,12,GO:0046488,phosphatidylinositol metabolic process,1
0,1,2,6,GO:0046533,negative regulation of photoreceptor cell differentiation,1
0,1,5,9,GO:0046579;GO:0051057,positive regulation of Ras protein signal transduction,1
0,1,2,11,GO:0046620,regulation of organ growth,1
0,1,2,8,GO:0046622,positive regulation of organ growth,1
0,1,4,7,GO:0046626;GO:1900076,regulation of cellular response to insulin stimulus,1
0,1,3,5,GO:0046627;GO:1900077,negative regulation of insulin receptor signaling pathway,1
0,1,2,5,GO:0046653,tetrahydrofolate metabolic process,1
0,1,3,27,GO:0046677,response to antibiotic,1
0,1,3,6,GO:0046686,response to cadmium ion,1
0,1,5,5,GO:0046717,acid secretion,1
0,1,5,7,GO:0046755,viral budding,1
0,1,6,9,GO:0046782;GO:0050434;GO:0048524,positive regulation of viral process,1
0,1,3,6,GO:0046797,viral procapsid maturation,1
0,1,2,6,GO:0046822,regulation of nucleocytoplasmic transport,1
0,1,6,12,GO:0046847,filopodium assembly,1
0,1,4,7,GO:0046886;GO:0032352;GO:0046885;GO:0032350,regulation of hormone metabolic process,1
0,1,2,11,GO:0046890,regulation of lipid biosynthetic process,1
0,1,3,5,GO:0046902;GO:0090559,regulation of mitochondrial membrane permeability,1
0,1,2,14,GO:0046916,cellular transition metal ion homeostasis,1
0,1,3,32,GO:0046942;GO:0015849,organic acid transport,1
0,1,3,25,GO:0048002;GO:0019882,antigen processing and presentation,1
0,1,2,9,GO:0048009,insulin-like growth factor receptor signaling pathway,1
0,1,6,34,GO:0048011;GO:0038179,neurotrophin TRK receptor signaling pathway,1
0,1,2,10,GO:0048013;GO:0043087,ephrin receptor signaling pathway,1
0,1,5,13,GO:0048015;GO:0048017,inositol lipid-mediated signaling,1
0,1,2,38,GO:0048024;GO:0043484;GO:0050684,regulation of RNA splicing,1
0,1,3,15,GO:0048025;GO:0033119;GO:0050686;GO:1903312,negative regulation of mRNA metabolic process,1
0,1,5,8,GO:0048041;GO:0007045;GO:0034333,adherens junction assembly,1
0,1,3,7,GO:0048145,regulation of fibroblast proliferation,1
0,1,4,5,GO:0048147,negative regulation of fibroblast proliferation,1
0,1,3,7,GO:0048208,COPII vesicle coating,1
0,1,2,6,GO:0048264;GO:0035143;GO:0035141,determination of ventral identity,1
0,1,3,10,GO:0048265;GO:0033555,multicellular organismal response to stress,1
0,1,2,10,GO:0048285,organelle fission,1
0,1,2,5,GO:0048286,lung alveolus development,1
0,1,2,17,GO:0048469,cell maturation,1
0,1,3,11,GO:0048484;GO:0042551,neuron maturation,1
0,1,2,10,GO:0048496,maintenance of animal organ identity,1
0,1,4,10,GO:0048514,blood vessel morphogenesis,1
0,1,5,7,GO:0048536,spleen development,1
0,1,4,7,GO:0048538,thymus development,1
0,1,3,5,GO:0048557,embryonic digestive tract morphogenesis,1
0,1,2,22,GO:0048608,reproductive structure development,1
0,1,2,7,GO:0048635,negative regulation of muscle organ development,1
0,1,2,8,GO:0048663,neuron fate commitment,1
0,1,2,9,GO:0048678,response to axon injury,1
0,1,6,5,GO:0048701,embryonic cranial skeleton morphogenesis,1
0,1,2,7,GO:0048704,embryonic skeletal system morphogenesis,1
0,1,2,8,GO:0048706,embryonic skeletal system development,1
0,1,2,30,GO:0048732,gland development,1
0,1,5,7,GO:0048745,smooth muscle tissue development,1
0,1,2,7,GO:0048749,compound eye development,1
0,1,4,18,GO:0048762;GO:0001837,mesenchymal cell differentiation,1
0,1,2,15,GO:0048771,tissue remodeling,1
0,1,2,26,GO:0048813,dendrite morphogenesis,1
0,1,2,12,GO:0048854,brain morphogenesis,1
0,1,3,6,GO:0048857;GO:0016332,establishment or maintenance of polarity of embryonic epithelium,1
0,1,5,8,GO:0050435,amyloid-beta metabolic process,1
0,1,2,7,GO:0050673,epithelial cell proliferation,1
0,1,3,40,GO:0050678,regulation of epithelial cell proliferation,1
0,1,6,26,GO:0050679,positive regulation of epithelial cell proliferation,1
0,1,3,17,GO:0050680,negative regulation of epithelial cell proliferation,1
0,1,2,6,GO:0050731;GO:0050730,regulation of peptidyl-tyrosine phosphorylation,1
0,1,3,6,GO:0050766;GO:0050764,positive regulation of phagocytosis,1
0,1,5,17,GO:0050772;GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1
0,1,3,7,GO:0050795,regulation of behavior,1
0,1,3,7,GO:0050847,progesterone receptor signaling pathway,1
0,1,5,23,GO:0050852;GO:0050851;GO:0002429;GO:0002768,immune response-activating cell surface receptor signaling pathway,1
0,1,4,20,GO:0050900,leukocyte migration,1
0,1,5,9,GO:0051000;GO:0032770;GO:0050999;GO:0032768,regulation of monooxygenase activity,1
0,1,3,7,GO:0051084;GO:0006458,'de novo' posttranslational protein folding,1
0,1,2,12,GO:0051099,positive regulation of binding,1
0,1,2,7,GO:0051100,negative regulation of binding,1
0,1,2,5,GO:0051103,DNA ligation involved in DNA repair,1
0,1,5,7,GO:0051145,smooth muscle cell differentiation,1
0,1,5,6,GO:0051146,striated muscle cell differentiation,1
0,1,2,11,GO:0051147,regulation of muscle cell differentiation,1
0,1,2,24,GO:0051168,nuclear export,1
0,1,2,5,GO:0051181,cofactor transport,1
0,1,2,9,GO:0051205,protein insertion into membrane,1
0,1,4,10,GO:0051216,cartilage development,1
0,1,2,8,GO:0051225,spindle assembly,1
0,1,2,12,GO:0051258,protein polymerization,1
0,1,3,13,GO:0051262,protein tetramerization,1
0,1,2,6,GO:0051289,protein homotetramerization,1
0,1,3,11,GO:0051291,protein heterooligomerization,1
0,1,2,5,GO:0051323,metaphase,1
0,1,2,7,GO:0051346,negative regulation of hydrolase activity,1
0,1,5,12,GO:0051353;GO:0051341,regulation of oxidoreductase activity,1
0,1,3,23,GO:0051403;GO:0031098,stress-activated protein kinase signaling cascade,1
0,1,-1,8,GO:0051436,obsolete negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,1
0,1,3,8,GO:0051489,regulation of filopodium assembly,1
0,1,2,17,GO:0051495;GO:0010638,positive regulation of organelle organization,1
0,1,2,10,GO:0051568;GO:0001555,histone H3-K4 methylation,1
0,1,3,20,GO:0051592,response to calcium ion,1
0,1,2,43,GO:0051604,protein maturation,1
0,1,2,18,GO:0051705,multi-organism behavior,1
0,1,2,9,GO:0051769,regulation of nitric-oxide synthase biosynthetic process,1
0,1,3,11,GO:0051781;GO:0051302,regulation of cell division,1
0,1,2,8,GO:0051823,regulation of synapse structural plasticity,1
0,1,2,10,GO:0051881,regulation of mitochondrial membrane potential,1
0,1,2,7,GO:0051896,regulation of protein kinase B signaling,1
0,1,2,5,GO:0051897,positive regulation of protein kinase B signaling,1
0,1,6,5,GO:0051930;GO:0051931,regulation of sensory perception,1
0,1,5,5,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,1
0,1,2,16,GO:0055001,muscle cell development,1
0,1,2,8,GO:0055002;GO:0055013;GO:0048739;GO:0048747,striated muscle cell development,1
0,1,2,10,GO:0055006,cardiac cell development,1
0,1,2,14,GO:0055008;GO:0060415,muscle tissue morphogenesis,1
0,1,3,5,GO:0055010,ventricular cardiac muscle tissue morphogenesis,1
0,1,2,16,GO:0055072,iron ion homeostasis,1
0,1,2,23,GO:0055076,transition metal ion homeostasis,1
0,1,4,115,GO:0055085,transmembrane transport,1
0,1,3,15,GO:0060021,roof of mouth development,1
0,1,2,13,GO:0060041,retina development in camera-type eye,1
0,1,5,7,GO:0060045;GO:0055023;GO:0060043;GO:0055021;GO:0055025;GO:0060421;GO:0055024;GO:0060420;GO:0045844;GO:0048636;GO:1901863,regulation of cardiac muscle tissue development,1
0,1,4,8,GO:0060052,neurofilament cytoskeleton organization,1
0,1,4,5,GO:0060059,embryonic retina morphogenesis in camera-type eye,1
0,1,2,5,GO:0060148;GO:0060147,positive regulation of posttranscriptional gene silencing,1
0,1,3,10,GO:0060253;GO:0060251;GO:0048715;GO:0048713;GO:2000974;GO:1905457;GO:2000973;GO:1901533;GO:1905456;GO:1901532;GO:0048711;GO:0045687;GO:0014015,regulation of glial cell proliferation,1
0,1,3,8,GO:0060271;GO:0044782,cilium assembly,1
0,1,3,12,GO:0060325,face morphogenesis,1
0,1,2,7,GO:0060348,bone development,1
0,1,2,5,GO:0060349,bone morphogenesis,1
0,1,2,5,GO:0060402;GO:0060401,calcium ion transport into cytosol,1
0,1,3,6,GO:0060411,cardiac septum morphogenesis,1
0,1,4,5,GO:0060441,epithelial tube branching involved in lung morphogenesis,1
0,1,2,7,GO:0060445,branching involved in salivary gland morphogenesis,1
0,1,4,6,GO:0060485,mesenchyme development,1
0,1,4,5,GO:0060487;GO:0060479,lung cell differentiation,1
0,1,3,12,GO:0060562,epithelial tube morphogenesis,1
0,1,3,6,GO:0060612;GO:0061448,adipose tissue development,1
0,1,2,14,GO:0060688,regulation of morphogenesis of a branching structure,1
0,1,2,33,GO:0060828,regulation of canonical Wnt signaling pathway,1
0,1,2,7,GO:0060968,regulation of gene silencing,1
0,1,6,9,GO:0061002;GO:0050774;GO:0061000;GO:2000171,negative regulation of dendrite morphogenesis,1
0,1,2,5,GO:0061035,regulation of cartilage development,1
0,1,2,20,GO:0061138;GO:0001763;GO:0048754,morphogenesis of a branching epithelium,1
0,1,3,38,GO:0062012,regulation of small molecule metabolic process,1
0,1,2,6,GO:0062014,negative regulation of small molecule metabolic process,1
0,1,2,6,GO:0065002;GO:0071806;GO:0044743,intracellular protein transmembrane transport,1
0,1,2,7,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,1
0,1,3,6,GO:0070192,chromosome organization involved in meiotic cell cycle,1
0,1,2,7,GO:0070208,protein heterotrimerization,1
0,1,4,6,GO:0070293;GO:0003014,renal system process,1
0,1,2,10,GO:0070374;GO:0070372,regulation of ERK1 and ERK2 cascade,1
0,1,2,9,GO:0070509;GO:0005513,detection of calcium ion,1
0,1,5,7,GO:0070555,response to interleukin-1,1
0,1,3,6,GO:0070593,dendrite self-avoidance,1
0,1,2,12,GO:0070830;GO:0120192;GO:0120193,tight junction assembly,1
0,1,2,32,GO:0070838;GO:0072511,divalent inorganic cation transport,1
0,1,2,7,GO:0070997,neuron death,1
0,1,3,8,GO:0071044;GO:0008334,histone mRNA metabolic process,1
0,1,8,5,GO:0071108,protein K48-linked deubiquitination,1
0,1,2,13,GO:0071158;GO:0071156,regulation of cell cycle arrest,1
0,1,3,8,GO:0071214;GO:0104004,cellular response to abiotic stimulus,1
0,1,4,6,GO:0071222,cellular response to lipopolysaccharide,1
0,1,2,6,GO:0071236,cellular response to antibiotic,1
0,1,2,9,GO:0071248;GO:0071241,cellular response to inorganic substance,1
0,1,2,13,GO:0071300;GO:0032526,response to retinoic acid,1
0,1,5,7,GO:0071347;GO:0002248;GO:0097709;GO:0051541;GO:0042789;GO:0009299;GO:0032722;GO:0032642;GO:0070101;GO:0001961;GO:0070099;GO:0060760;GO:0010870;GO:0010869;GO:0010575;GO:0010574;GO:0043619;GO:0043618;GO:0043620;GO:0032909;GO:0071634;GO:0010573,regulation of receptor biosynthetic process,1
0,1,4,8,GO:0071456;GO:0036294;GO:0071453,cellular response to hypoxia,1
0,1,2,5,GO:0071478,cellular response to radiation,1
0,1,3,20,GO:0071496,cellular response to external stimulus,1
0,1,4,6,GO:0071816;GO:0045048,tail-anchored membrane protein insertion into ER membrane,1
0,1,2,24,GO:0072175;GO:0001838,epithelial tube formation,1
0,1,3,12,GO:0072300;GO:0072216;GO:0072298;GO:0090193;GO:0072215;GO:0090192,regulation of glomerulus development,1
0,1,4,43,GO:0072330,monocarboxylic acid biosynthetic process,1
0,1,7,8,GO:0072383;GO:0047496;GO:0072386;GO:0099518,plus-end-directed vesicle transport along microtubule,1
0,1,2,11,GO:0072384,organelle transport along microtubule,1
0,1,5,5,GO:0072499,photoreceptor cell axon guidance,1
0,1,3,20,GO:0072525,pyridine-containing compound biosynthetic process,1
0,1,2,15,GO:0072527;GO:0006220,pyrimidine-containing compound metabolic process,1
0,1,3,9,GO:0072528;GO:0006221,pyrimidine-containing compound biosynthetic process,1
0,1,5,63,GO:0072657,protein localization to membrane,1
0,1,2,18,GO:0090068,positive regulation of cell cycle process,1
0,1,3,10,GO:0090084;GO:0090083,negative regulation of inclusion body assembly,1
0,1,4,6,GO:0090103,cochlea morphogenesis,1
0,1,4,43,GO:0090150,establishment of protein localization to membrane,1
0,1,4,13,GO:0090162,establishment of epithelial cell polarity,1
0,1,3,7,GO:0090175,regulation of establishment of planar polarity,1
0,1,2,18,GO:0090184;GO:0090183,regulation of kidney development,1
0,1,3,14,GO:0090263,positive regulation of canonical Wnt signaling pathway,1
0,1,2,26,GO:0090305,nucleic acid phosphodiester bond hydrolysis,1
0,1,3,5,GO:0097150,neuronal stem cell population maintenance,1
0,1,3,9,GO:0097305,response to alcohol,1
0,1,2,5,GO:0098630,aggregation of unicellular organisms,1
0,1,1,10,GO:0098743,cell aggregation,1
0,1,3,8,GO:0098815;GO:0071625,modulation of excitatory postsynaptic potential,1
0,1,2,11,GO:0110110,positive regulation of animal organ morphogenesis,1
0,1,2,7,GO:0110111,negative regulation of animal organ morphogenesis,1
0,1,2,12,GO:0120032;GO:0060491,regulation of plasma membrane bounded cell projection assembly,1
0,1,3,5,GO:1901068,guanosine-containing compound metabolic process,1
0,1,2,24,GO:1901568;GO:0006690,fatty acid derivative metabolic process,1
0,1,4,13,GO:1901570,fatty acid derivative biosynthetic process,1
0,1,4,22,GO:1901617,organic hydroxy compound biosynthetic process,1
0,1,4,6,GO:1901661,quinone metabolic process,1
0,1,4,38,GO:1902600;GO:0098660;GO:0098662;GO:0098655,inorganic ion transmembrane transport,1
0,1,5,8,GO:1902692;GO:0072091;GO:2000177,regulation of neural precursor cell proliferation,1
0,1,2,6,GO:1902743,regulation of lamellipodium organization,1
0,1,4,10,GO:1902850,microtubule cytoskeleton organization involved in mitosis,1
0,1,2,5,GO:1903305,regulation of regulated secretory pathway,1
0,1,4,7,GO:1903313,positive regulation of mRNA metabolic process,1
0,1,2,10,GO:1903522,regulation of blood circulation,1
0,1,2,7,GO:1903524,positive regulation of blood circulation,1
0,1,3,10,GO:1904062;GO:0022898;GO:0034765;GO:0032409;GO:1904064;GO:0032411;GO:0034767,regulation of cation transmembrane transport,1
0,1,2,6,GO:1905039;GO:0098656;GO:1903825,carboxylic acid transmembrane transport,1
0,1,2,20,GO:1905330,regulation of morphogenesis of an epithelium,1
0,1,2,10,GO:1990542,mitochondrial transmembrane transport,1
0,1,2,35,GO:2000027,regulation of animal organ morphogenesis,1
0,1,7,13,GO:2000134;GO:1902807;GO:2000045;GO:1902806,regulation of cell cycle G1/S phase transition,1
0,1,2,5,GO:2000136,regulation of cell proliferation involved in heart morphogenesis,1
0,1,3,5,GO:2000178,negative regulation of neural precursor cell proliferation,1
0,1,2,11,GO:2000241,regulation of reproductive process,1
0,1,2,8,GO:2000273;GO:0010469,regulation of signaling receptor activity,1
0,1,5,7,GO:2000736,regulation of stem cell differentiation,1
0,1,3,7,GO:2000826,regulation of heart morphogenesis,1
0,1,3,7,GO:2001259;GO:2001257;GO:0032412;GO:0032414,regulation of cation channel activity,1
0,0.001392996,5,19,GO:0050792;GO:0043903,regulation of symbiosis,
0,0.043269067,3,12,GO:0006368;GO:0006354,DNA-templated transcription,
0,0.06384889,6,9,GO:0006313;GO:0032196,transposition,
0,0.258250271,2,9,GO:0042147,retrograde transport,
0,0.326799346,2,29,GO:0006352,DNA-templated transcription,
0,0.680658773,3,34,GO:0000398;GO:0000377;GO:0000375,RNA splicing,
0,0.795817694,5,867,GO:0006355;GO:1903506;GO:2001141,regulation of transcription,
0,1,3,23,GO:0000184,nuclear-transcribed mRNA catabolic process,
0,1,2,14,GO:0000381,regulation of alternative mRNA splicing,
0,1,2,13,GO:0006353,DNA-templated transcription,
0,1,2,10,GO:0006890,retrograde vesicle-mediated transport,
0,1,6,10,GO:0006911;GO:0099024;GO:0010324,phagocytosis,
0,1,2,7,GO:0006930,substrate-dependent cell migration,
0,1,7,9,GO:0006958,complement activation,
0,1,6,10,GO:0007188;GO:0007187,G protein-coupled receptor signaling pathway,
0,1,5,23,GO:0015991;GO:0015988;GO:0099131;GO:0099132;GO:0090662,energy coupled proton transmembrane transport,
0,1,2,11,GO:0032784,regulation of DNA-templated transcription,
0,1,3,6,GO:0035152,regulation of tube architecture,
0,1,2,5,GO:0035249,synaptic transmission,
0,1,2,30,GO:0040029,regulation of gene expression,
0,1,6,7,GO:0051966,regulation of synaptic transmission,
0,1,7,5,GO:0060071,Wnt signaling pathway,